P38A
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S444 | Sugiyama | SHTN1 KIAA1598 | RPVNQTARPKTKPESSKGCEsAVDELKGILGtLNKSTSSRs |
| A0MZ66 | S493 | Sugiyama | SHTN1 KIAA1598 | sEtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsV |
| A0MZ66 | S494 | Sugiyama | SHTN1 KIAA1598 | EtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsVs |
| A6NKT7 | S919 | Sugiyama | RGPD3 RGP3 | tKGSSNTEFKSTKEGFSIPVsADGFKFGIsEPGNQEKKSEK |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00257 | T497 | PSP | CBX4 | CVKTRSEAGEPPSSLQVKPEtPASAAVAVAAAAAPTTTAEK |
| O00410 | S974 | Sugiyama | IPO5 KPNB3 RANBP5 | VIQSADSKTKENVNAtENCIsAVGKIMKFKPDCVNVEEVLP |
| O00418 | S396 | GPS6|SIGNOR|iPTMNet | EEF2K | LsENSGDENMSDVTFDsLPSsPsSATPHSQKLDHLHWPVFS |
| O00499 | S298 | Sugiyama | BIN1 AMPHL | TFtVKAQPsDNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEP |
| O00499 | T307 | Sugiyama | BIN1 AMPHL | DNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEPAGGAtPGAt |
| O00571 | S90 | Sugiyama | DDX3X DBX DDX3 | ssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRsDyDGIGsR |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14579 | S307 | Sugiyama | COPE | IKEYQAKENDFDRLVLQyAPsA___________________ |
| O14672 | S630 | Sugiyama | ADAM10 KUZ MADM | TGSVQWSRHFSGRTITLQPGsPCNDFRGYCDVFMRCRLVDA |
| O14715 | S918 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | tKGSSNTEFKSTKEGFSIPVsADGFKFGIsEPGNQEKKREK |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O14979 | S241 | Sugiyama | HNRNPDL HNRPDL JKTBP | KRAKALKGKEPPKKVFVGGLsPDtsEEQIKEYFGAFGEIEN |
| O15151 | S314 | PSP | MDM4 MDMX | TDVEVTSEDEWQCTECKKFNsPSKRYCFRCWALRKDWYSDC |
| O15198 | T136 | PSP | SMAD9 MADH6 MADH9 SMAD8 | PFGSKQKEVCINPYHYRRVEtPVLPPVLVPRHSEYNPQLSL |
| O43257 | T103 | SIGNOR|iPTMNet|PSP | ZNHIT1 CGBP1 ZNFN4A1 | NFQALLEEQNLSVAEGPNYLtACAGPPSRPQRPFCAVCGFP |
| O43399 | S104 | Sugiyama | TPD52L2 | stLGELKQNLsRsWHDVQVssAyVKTSEKLGEWNEKVTQSD |
| O43464 | S142 | PSP | HTRA2 OMI PRSS25 | WGGGRGPPAVLAAVPSPPPAsPRSQyNFIADVVEKTAPAVV |
| O43521 | S69 | SIGNOR | BCL2L11 BIM | GGEGDSCPHGsPQGPLAPPAsPGPFATRsPLFIFMRRSsLL |
| O43524 | S12 | PSP | FOXO3 FKHRL1 FOXO3A | _________MAEAPAsPAPLsPLEVELDPEFEPQSRPRsCt |
| O43524 | S294 | PSP | FOXO3 FKHRL1 FOXO3A | LQTAPEsADDsPsQLsKWPGsPtSRssDELDAWTDFRsRTN |
| O43524 | S344 | PSP | FOXO3 FKHRL1 FOXO3A | LSPIMAsTELDEVQDDDAPLsPMLYSSSASLSPSVSKPCTV |
| O43524 | S425 | PSP | FOXO3 FKHRL1 FOXO3A | GGLMQRSSsFPYTTKGsGLGsPtssFNstVFGPssLNsLRQ |
| O43524 | S7 | SIGNOR|PSP | FOXO3 FKHRL1 FOXO3A | ______________MAEAPAsPAPLsPLEVELDPEFEPQSR |
| O43684 | S211 | PSP | BUB3 | KQGyVLSSIEGRVAVEyLDPsPEVQKKKYAFKCHRLKENNI |
| O43707 | T612 | Sugiyama | ACTN4 | KEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPK |
| O43707 | T615 | Sugiyama | ACTN4 | QRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPKRDH |
| O43707 | Y611 | Sugiyama | ACTN4 | HKEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVP |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60260 | S131 | PSP | PRKN PARK2 | VLPGDSVGLAVILHTDsRKDsPPAGsPAGRSIyNSFYVYCK |
| O60361 | S110 | Sugiyama | NME2P1 | RGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDYKSC |
| O60381 | S402 | SIGNOR|PSP | HBP1 | sCGGPGGQDFARSGFSKNCGsPGSSQLSSNSLYAKAVKNHs |
| O60664 | S91 | Sugiyama | PLIN3 M6PRBP1 TIP47 | TAAAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQ |
| O60701 | T185 | Sugiyama | UGDH | EGTAIKDLKNPDRVLIGGDEtPEGQRAVQALCAVYEHWVPR |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O75179 | S2042 | Sugiyama | ANKRD17 GTAR KIAA0697 | TAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLD |
| O75179 | S2045 | Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75582 | S360 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KA5 MSK1 | RDELDVsNFAEEFtEMDPtYsPAALPQssEKLFQGYsFVAP |
| O75582 | S376 | SIGNOR|iPTMNet | RPS6KA5 MSK1 | DPtYsPAALPQssEKLFQGYsFVAPsILFKRNAAVIDPLQF |
| O75582 | T581 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KA5 MSK1 | IKIIDFGFARLKPPDNQPLKtPCFTLHYAAPELLNQNGYDE |
| O75582 | T700 | GPS6 | RPS6KA5 MSK1 | GLRYNEWLQDGSQLSSNPLMtPDILGSSGAAVHTCVKAtFH |
| O75676 | S196 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KA4 MSK2 | VLTDFGLSKEFLTEEKERtFsFCGTIEYMAPEIIRSKTGHG |
| O75676 | S343 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KA4 MSK2 | RsELDVGNFAEEFTRLEPVysPPGsPPPGDPRIFQGYsFVA |
| O75676 | S347 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KA4 MSK2 | DVGNFAEEFTRLEPVysPPGsPPPGDPRIFQGYsFVAPsIL |
| O75676 | S360 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KA4 MSK2 | PVysPPGsPPPGDPRIFQGYsFVAPsILFDHNNAVMTDGLE |
| O75676 | T568 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KA4 MSK2 | KIIDFGFARLRPQSPGVPMQtPCFTLQYAAPELLAQQGYDE |
| O75794 | S314 | Sugiyama | CDC123 C10orf7 D123 | VtVQPsPyLsyRLPKDFVDLsTGEDAHKLIDFLKLKRNQQE |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75822 | T109 | Sugiyama | EIF3J EIF3S1 PRO0391 | KKRQEEIKKRLEEPEEPKVLtPEEQLADKLRLKKLQEEsDL |
| O75828 | S56 | Sugiyama | CBR3 SDR21C2 | TARDVARGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| O75928 | S113 | SIGNOR | PIAS2 PIASX | EPDLAVAGIHSLPSTSVTPHsPSsPVGSVLLQDTKPTFEMQ |
| O75928 | S116 | SIGNOR | PIAS2 PIASX | LAVAGIHSLPSTSVTPHsPSsPVGSVLLQDTKPTFEMQQPS |
| O76080 | S58 | Sugiyama | ZFAND5 ZA20D2 ZNF216 | LQRQQNsGRMsPMGtAsGsNsPtsDSASVQRADtsLNNCEG |
| O94979 | S186 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | QPPEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIK |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95359 | S2317 | Sugiyama | TACC2 | MPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTF |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95644 | S172 | SIGNOR|PSP | NFATC1 NFAT2 NFATC | PstATLSLPsLEAYRDPsCLsPAssLSSRSCNSEAsSYESN |
| O95863 | S107 | PSP | SNAI1 SNAH | ELTSLsDEDsGKGsQPPsPPsPAPsSFSsTSVsSLEAEAYA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T309 | Sugiyama | LDHA PIG19 | LSVPCILGQNGISDLVKVTLtsEEEARLKKsADtLWGIQKE |
| P00338 | T95 | Sugiyama | LDHA PIG19 | PKIVSGKDyNVTANsKLVIItAGARQQEGEsRLNLVQRNVN |
| P00505 | Y179 | Sugiyama | GOT2 KYAT4 | KPTWGNHtPIFRDAGMQLQGyRYYDPKtCGFDFtGAVEDIS |
| P00533 | S1039 | PSP | EGFR ERBB ERBB1 HER1 | PQQGFFssPStsRTPLLssLsAtsNNstVACIDRNGLQsCP |
| P00533 | T1041 | PSP | EGFR ERBB ERBB1 HER1 | QGFFssPStsRTPLLssLsAtsNNstVACIDRNGLQsCPIK |
| P00533 | T693 | PSP | EGFR ERBB ERBB1 HER1 | IVRKRtLRRLLQERELVEPLtPsGEAPNQALLRILKETEFK |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P02511 | S59 | PSP | CRYAB CRYA2 HSPB5 | PTSTSLsPFYLRPPSFLRAPsWFDTGLSEMRLEKDRFsVNL |
| P03372 | S118 | SIGNOR|PSP | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P03372 | S294 | PSP | ESR1 ESR NR3A1 | GEGRGEVGsAGDMRAANLWPsPLMIKRSKKNsLALSLtADQ |
| P03372 | T311 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ESR1 ESR NR3A1 | LWPsPLMIKRSKKNsLALSLtADQMVSALLDAEPPILYSEY |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T124 | Sugiyama | ALDOA ALDA | VVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGAD |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04075 | T65 | Sugiyama | ALDOA ALDA | QsIGtENtEENRRFyRQLLLtADDRVNPCIGGVILFHETLY |
| P04083 | S34 | Sugiyama | ANXA1 ANX1 LPC1 | IENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKA |
| P04083 | S37 | Sugiyama | ANXA1 ANX1 LPC1 | EEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMV |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04150 | S203 | PSP | NR3C1 GRL | LYTTDQSTFDILQDLEFssGsPGKETNEsPWRSDLLIDENC |
| P04150 | S211 | SIGNOR|PSP | NR3C1 GRL | FDILQDLEFssGsPGKETNEsPWRSDLLIDENCLLsPLAGE |
| P04150 | S226 | PSP | NR3C1 GRL | KETNEsPWRSDLLIDENCLLsPLAGEDDSFLLEGNSNEDCK |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04637 | S15 | SIGNOR|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S33 | SIGNOR|PSP | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S392 | SIGNOR|iPTMNet | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04637 | S46 | SIGNOR|PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04792 | S176 | PSP | HSPB1 HSP27 HSP28 | sLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S228 | Sugiyama | ATP1A1 | ANGCKVDNssLtGESEPQtRsPDFtNENPLETRNIAFFSTN |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05198 | S52 | PSP | EIF2S1 EIF2A | AYVSLLEYNNIEGMILLsELsRRRIRSINKLIRIGRNECVV |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S79 | Sugiyama | RPLP2 D11S2243E RPP2 | IGKLAsVPAGGAVAVsAAPGsAAPAAGsAPAAAEEKKDEKK |
| P05387 | S86 | Sugiyama | RPLP2 D11S2243E RPP2 | PAGGAVAVsAAPGsAAPAAGsAPAAAEEKKDEKKEEsEEsD |
| P05787 | S74 | SIGNOR|ELM|iPTMNet|EPSD|PSP | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06400 | S249 | PSP | RB1 | LsPPMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLEN |
| P06400 | S567 | SIGNOR|PSP | RB1 | IKHLERCEHRIMESLAWLSDsPLFDLIKQSKDREGPTDHLE |
| P06400 | S838 | PSP | RB1 | GLPtPtKMtPRSRILVSIGEsFGtsEKFQKINQMVCNsDRV |
| P06400 | T252 | PSP | RB1 | PMLLKEPYKTAVIPINGsPRtPRRGQNRSARIAKQLENDTR |
| P06400 | T841 | PSP | RB1 | tPtKMtPRSRILVSIGEsFGtsEKFQKINQMVCNsDRVLKR |
| P06702 | T113 | PSP | S100A9 CAGB CFAG MRP14 | KMHEGDEGPGHHHKPGLGEGtP___________________ |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T96 | Sugiyama | LDHB | PKIVADKDysVtANSKIVVVtAGVRQQEGEsRLNLVQRNVN |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | T428 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | DKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFPA |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S172 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | ISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSVHQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07814 | S688 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | DIIQLQRRGFFICDQPyEPVsPysCKEAPCVLIyIPDGHtK |
| P07814 | S691 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | QLQRRGFFICDQPyEPVsPysCKEAPCVLIyIPDGHtKEMP |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T94 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtIAKSG |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07954 | T90 | SIGNOR|PSP | FH | AQTVRsTMNFKIGGVTERMPtPVIKAFGILKRAAAEVNQDy |
| P08151 | S937 | SIGNOR | GLI1 GLI | DAPAQEPSyQsPKFLGGSQVsPSRAKAPVNTYGPGFGPNLP |
| P08151 | S982 | SIGNOR | GLI1 GLI | GSYPTPsPCHENFVVGANRAsHRAAAPPRLLPPLPTCYGPL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P10275 | S651 | PSP | AR DHTR NR3C4 | KLKKLGNLKLQEEGEAsSttsPTEETTQKLTVSHIEGYECQ |
| P10415 | S87 | SIGNOR|PSP | BCL2 | ARtsPLQtPAAPGAAAGPALsPVPPVVHLTLRQAGDDFSRR |
| P10415 | T56 | SIGNOR|PSP | BCL2 | GAAPPGAAPAPGIFSSQPGHtPHPAASRDPVARtsPLQtPA |
| P10636 | S235 | GPS6 | MAPT MAPTL MTBT1 TAU | KEEVDEDRDVDESsPQDsPPsKAsPAQDGRPPQTAAREATS |
| P10636 | S396 | GPS6 | MAPT MAPTL MTBT1 TAU | ARMVSKSKDGtGSDDKKAKTsTRSsAKtLKNRPCLsPKHPT |
| P10636 | T50 | GPS6 | MAPT MAPTL MTBT1 TAU | tMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDAKstP |
| P10636 | T548 | SIGNOR | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P10636 | T69 | GPS6 | MAPT MAPTL MTBT1 TAU | QtPTEDGsEEPGsETSDAKstPtAEDVTAPLVDEGAPGKQA |
| P10809 | S175 | Sugiyama | HSPD1 HSP60 | LKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKVGR |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T113 | Sugiyama | HSPD1 HSP60 | IGAKLVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISK |
| P10809 | T114 | Sugiyama | HSPD1 HSP60 | GAKLVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKG |
| P10809 | T164 | Sugiyama | HSPD1 HSP60 | VMLAVDAVIAELKKQsKPVttPEEIAQVAtIsANGDKEIGN |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P11142 | S221 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHF |
| P11142 | T222 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFI |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11362 | S777 | SIGNOR|PSP | FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR | IVALTSNQEyLDLSMPLDQysPsFPDTRsstCsSGEDsVFS |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12268 | S122 | Sugiyama | IMPDH2 IMPD2 | NEVRKVKKyEQGFITDPVVLsPKDRVRDVFEAKARHGFCGI |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | S128 | Sugiyama | CKB CKBB | TDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsR |
| P12277 | T322 | Sugiyama | CKB CKBB | LGKHEKFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRL |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P13473 | T211 | PSP | LAMP2 | KDKTSTVAPTIHTTVPSPTTtPtPKEKPEAGTYSVNNGNDT |
| P13473 | T213 | PSP | LAMP2 | KTSTVAPTIHTTVPSPTTtPtPKEKPEAGTYSVNNGNDTCL |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13667 | S124 | Sugiyama | PDIA4 ERP70 ERP72 | IANILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILK |
| P13667 | S482 | Sugiyama | PDIA4 ERP70 ERP72 | VKDLGLsEsGEDVNAAILDEsGKKFAMEPEEFDsDtLREFV |
| P13726 | S285 | PSP | F3 | ILVIILAISLHKCRKAGVGQsWKENsPLNVs__________ |
| P13726 | S290 | SIGNOR|PSP | F3 | LAISLHKCRKAGVGQsWKENsPLNVs_______________ |
| P13798 | S304 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | YVDLIGGKCELLSDDsLAVssPRLSPDQCRIVYLQYPSLIP |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | S108 | Sugiyama | PRKCSH G19P1 | PSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQ |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14598 | S345 | ELM|iPTMNet|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | RRNsVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAV |
| P14598 | S348 | ELM|iPTMNet|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15259 | T96 | Sugiyama | PGAM2 PGAMM | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQVKIWR |
| P15336 | S90 | SIGNOR|iPTMNet | ATF2 CREB2 CREBP1 | PtPtRFLKNCEEVGLFNELAsPFENEFKKASEDDIKKMPLD |
| P15336 | T69 | SIGNOR|iPTMNet|PSP|Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | SIGNOR|iPTMNet|EPSD|PSP|Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15531 | S125 | Sugiyama | NME1 NDPKA NM23 | RGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDyTsC |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P15923 | S139 | SIGNOR | TCF3 BHLHB21 E2A ITF1 | GLTQAGFLSGELALNSPGPLsPsGMKGTSQYYPSYsGssRR |
| P16152 | S56 | Sugiyama | CBR1 CBR CRN SDR21C1 | TARDVTRGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| P16949 | S25 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P17066 | T224 | Sugiyama | HSPA6 HSP70B' | GGTFDVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFM |
| P17181 | S532 | PSP | IFNAR1 IFNAR | ATVEETNQTDEDHKKySSQTsQDsGNysNEDESESKTSEEL |
| P17275 | S79 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | JUNB | GPEGGGGGSYFSGQGsDTGAsLKLASSELERLIVPNSNGVI |
| P17275 | T102 | iPTMNet | JUNB | LASSELERLIVPNSNGVITttPtPPGQyFYPRGGGsGGGAG |
| P17275 | T104 | iPTMNet | JUNB | SSELERLIVPNSNGVITttPtPPGQyFYPRGGGsGGGAGGA |
| P17302 | S279 | PSP | GJA1 GJAL | DCGsQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCR |
| P17302 | S282 | PSP | GJA1 GJAL | sQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCRNYN |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17812 | S571 | Sugiyama | CTPS1 CTPS | LSHYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17812 | S574 | Sugiyama | CTPS1 CTPS | YLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD___ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17844 | T446 | PSP | DDX5 G17P1 HELR HLR1 | IHRIGRTARSTKtGtAytFFtPNNIKQVSDLISVLREANQA |
| P17844 | T564 | PSP | DDX5 G17P1 HELR HLR1 | SFGSNFVSAGIQTsFRTGNPtGTYQNGYDSTQQYGSNVPNM |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18669 | T96 | Sugiyama | PGAM1 PGAMA CDABP0006 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| P18754 | T131 | Sugiyama | RCC1 CHC1 | VPGKVELQEKVVQVsAGDsHtAALTDDGRVFLWGSFRDNNG |
| P18850 | T166 | SIGNOR|PSP | ATF6 | EPLKEDKPVTGPRNKTENGLtPKKKIQVNSKPSIQPKPLLL |
| P18887 | T281 | Sugiyama | XRCC1 | PPAQLsPsVPKRPKLPAPTRtPAtAPVPARAQGAVTGKPRG |
| P18887 | T284 | Sugiyama | XRCC1 | QLsPsVPKRPKLPAPTRtPAtAPVPARAQGAVTGKPRGEGT |
| P19419 | S383 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ELK1 | tPVLLtPSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSA |
| P19419 | S389 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ELK1 | PSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSAQVHIPS |
| P19525 | T451 | PSP | EIF2AK2 PKR PRKR | GDFGLVtsLKNDGKRtRSKGtLRyMsPEQIssQDYGKEVDL |
| P19634 | S723 | SIGNOR|ELM|iPTMNet|EPSD|PSP | SLC9A1 APNH1 NHE1 | sDPLAyEPKEDLPVItIDPAsPQsPEsVDLVNEELKGKVLG |
| P19634 | S726 | SIGNOR|ELM|iPTMNet|EPSD|PSP | SLC9A1 APNH1 NHE1 | LAyEPKEDLPVItIDPAsPQsPEsVDLVNEELKGKVLGLSR |
| P19634 | S729 | SIGNOR|ELM|iPTMNet|EPSD|PSP | SLC9A1 APNH1 NHE1 | EPKEDLPVItIDPAsPQsPEsVDLVNEELKGKVLGLSRDPA |
| P19634 | T718 | SIGNOR|ELM|iPTMNet|EPSD|PSP | SLC9A1 APNH1 NHE1 | RARIGsDPLAyEPKEDLPVItIDPAsPQsPEsVDLVNEELK |
| P20265 | S91 | PSP | POU3F2 BRN2 OCT7 OTF7 | GGGGGGGGGGGGGGGGGGDGsPWSTsPLGQPDIKPSVVVQQ |
| P20265 | S96 | PSP | POU3F2 BRN2 OCT7 OTF7 | GGGGGGGGGGGGGDGsPWSTsPLGQPDIKPSVVVQQGGRGD |
| P20265 | T440 | PSP | POU3F2 BRN2 OCT7 OTF7 | PGAEDVYGGsRDtPPHHGVQtPVQ_________________ |
| P20290 | T182 | Sugiyama | BTF3 NACB OK/SW-cl.8 | LRRLAEALPKQsVDGKAPLAtGEDDDDEVPDLVENFDEAsK |
| P21333 | S1081 | Sugiyama | FLNA FLN FLN1 | AVAPTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLG |
| P21333 | S2319 | Sugiyama | FLNA FLN FLN1 | VQEPGDyEVsVKFNEEHIPDsPFVVPVAsPsGDARRLtVss |
| P21333 | S2327 | Sugiyama | FLNA FLN FLN1 | VsVKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKV |
| P21333 | S2329 | Sugiyama | FLNA FLN FLN1 | VKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKVNQ |
| P21397 | S209 | PSP | MAOA | VSALWFLWYVKQCGGTTRIFsVTNGGQERKFVGGSGQVSER |
| P21462 | S342 | PSP | FPR1 | RALtEDstQtsDtAtNstLPsAEVELQAK____________ |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22392 | S125 | Sugiyama | NME2 NM23B | RGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDyKSC |
| P22415 | T153 | SIGNOR|PSP | USF1 BHLHB11 USF | SGSTAAVVTTQGSEALLGQAtPPGTGQFFVMMSPQEVLQGG |
| P22626 | S201 | Sugiyama | HNRNPA2B1 HNRPA2B1 | NAEVRKALsRQEMQEVQssRsGRGGNFGFGDsRGGGGNFGP |
| P23246 | T687 | Sugiyama | SFPQ PSF | FGQGGAGPVGGQGPRGMGPGtPAGyGRGREEYEGPNKKPRF |
| P23284 | T108 | Sugiyama | PPIB CYPB | YKNSKFHRVIKDFMIQGGDFtRGDGtGGKsIyGERFPDENF |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23396 | S224 | Sugiyama | RPS3 OK/SW-cl.26 | LPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVPtA_ |
| P23396 | T220 | Sugiyama | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23769 | S192 | PSP | GATA2 | GFPPtPPKEVsPDPSTTGAAsPASSSAGGSAARGEDKDGVK |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P23921 | T774 | Sugiyama | RRM1 RR1 | KEKLKDKEKVSKEEEEKERNtAAMVCsLENRDECLMCGS__ |
| P23975 | T30 | PSP | SLC6A2 NAT1 NET1 SLC6A5 | VQPENNGADTGPEQPLRARKtAELLVVKERNGVQCLLAPRD |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24928 | S1913 | Sugiyama | POLR2A POLR2 | PtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPt |
| P24928 | S1920 | Sugiyama | POLR2A POLR2 | PVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKGstY |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P25789 | S13 | Sugiyama | PSMA4 HC9 PSC9 | ________MSRRyDsRttIFsPEGRLYQVEYAMEAIGHAGT |
| P26640 | S299 | Sugiyama | VARS1 G7A VARS VARS2 | TyDLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFF |
| P26640 | S301 | Sugiyama | VARS1 G7A VARS VARS2 | DLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFKP |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27708 | S1038 | Sugiyama | CAD | QLPNNMAMALHRQQCRVLGtsPEAIDSAENRFKFSRLLDTI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S696 | PSP | MAP4 | PVVSGTGNDIttPPNKELPPsPEKKTKPLATTQPAKtstsK |
| P27816 | S787 | PSP | MAP4 | PsKDVKPKPIADAKAPEKRAsPsKPAsAPASRSGSKSTQTV |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28074 | S175 | Sugiyama | PSMB5 LMPX MB1 X | SMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSVYAY |
| P28324 | S381 | PSP | ELK4 SAP1 | tPIILtPSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFP |
| P28324 | S387 | PSP | ELK4 SAP1 | PSPLLSSIHFWSTLsPVAPLsPARLQGANTLFQFPSVLNSH |
| P29144 | S93 | Sugiyama | TPP2 | SGDVNTATEVEPKDGEIVGLsGRVLKIPASWTNPSGKYHIG |
| P29353 | S54 | PSP | SHC1 SHC SHCA | LPsPSASSLGPILPPLPGDDsPTTLCSFFPRMSNLRLANPA |
| P29353 | T386 | PSP | SHC1 SHC SHCA | MRLREGAAPGAARPTAPNAQtPsHLGATLPVGQPVGGDPEV |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29401 | Y447 | Sugiyama | TKT | SQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANTKGI |
| P29474 | S114 | PSP | NOS3 | CTPRRCLGSLVFPRKLQGRPsPGPPAPEQLLSQARDFINQY |
| P29474 | S600 | PSP | NOS3 | PENGESFAAALMEMSGPYNSsPRPEQHKSYKIRFNsISCSD |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S65 | Sugiyama | EEF1D EF1D | VILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRIA |
| P29692 | S71 | Sugiyama | EEF1D EF1D | ARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVEN |
| P29692 | T73 | Sugiyama | EEF1D EF1D | ARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQs |
| P29966 | S26 | Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30041 | T49 | Sugiyama | PRDX6 AOP2 KIAA0106 | LGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKLI |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30101 | T437 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KELGEKLsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsP |
| P30279 | T280 | PSP | CCND2 | QYRQDQRDGsKsEDELDQAstPTDVRDIDL___________ |
| P30305 | S101 | SIGNOR | CDC25B CDC25HU2 | SRSRLTHLsLsRRASESSLSsEsSESSDAGLCMDSPSPMDP |
| P30305 | S103 | SIGNOR | CDC25B CDC25HU2 | SRLTHLsLsRRASESSLSsEsSESSDAGLCMDSPSPMDPHM |
| P30305 | S323 | GPS6|SIGNOR | CDC25B CDC25HU2 | KEEEKDLVMYSKCQRLFRsPsMPCSVIRPILKRLERPQDRD |
| P30305 | S375 | GPS6|SIGNOR | CDC25B CDC25HU2 | tPPEEQQEAEEPKARVLRsKsLCHDEIENLLDSDHRELIGD |
| P30307 | S216 | GPS6|SIGNOR|iPTMNet | CDC25C | EFsLKDQEAKVSRsGLYRsPsMPENLNRPRLKQVEKFKDNt |
| P31150 | S316 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | QVIRIICILSHPIKNtNDANsCQIIIPQNQVNRKSDIYVCM |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31645 | T616 | PSP | SLC6A4 HTT SERT | RLIITPGtFKERIIKsItPEtPTEIPCGDIRLNAV______ |
| P31751 | S474 | SIGNOR | AKT2 | DRyDsLGLLELDQRTHFPQFsysAsIRE_____________ |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31943 | T107 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | KSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSKEEI |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S248 | Sugiyama | SFN HME1 | tLWTADNAGEEGGEAPQEPQs____________________ |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32929 | S56 | Sugiyama | CTH | AVVPPISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVA |
| P34897 | S417 | Sugiyama | SHMT2 | ERVLELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFR |
| P34897 | T420 | Sugiyama | SHMT2 | LELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFREDD |
| P34931 | T224 | Sugiyama | HSPA1L | GGTFDVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFV |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35236 | S93 | SIGNOR|PSP | PTPN7 | HFLRTAGHPLTRWALQRQPPsPKQLEEEFLKIPsNFVsPED |
| P35236 | T66 | SIGNOR|PSP | PTPN7 | VALMLDVRSLGAVEPICsVNtPREVtLHFLRTAGHPLTRWA |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35637 | S346 | Sugiyama | FUS TLS | TDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFsGNPIKV |
| P35638 | S79 | SIGNOR|iPTMNet|PSP | DDIT3 CHOP CHOP10 GADD153 | SLAWLTEEEPEPAEVTSTSQsPHsPDSSQSSLAQEEEEEDQ |
| P35638 | S82 | SIGNOR|iPTMNet|PSP | DDIT3 CHOP CHOP10 GADD153 | WLTEEEPEPAEVTSTSQsPHsPDSSQSSLAQEEEEEDQGRT |
| P35900 | S13 | SIGNOR | KRT20 | ________MDFSRRSFHRSLsSSLQAPVVSTVGMQRLGTTP |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36956 | S63 | PSP | SREBF1 BHLHD1 SREBP1 | FPGLFDPPYAGSGAGGtDPAsPDTSSPGSLSPPPATLSSSL |
| P36956 | T426 | PSP | SREBF1 BHLHD1 SREBP1 | SGGNTDVLMEGVKTEVEDTLtPPPsDAGsPFQSsPLSLGSR |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38606 | S125 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | PLSDISSQTQSIYIPRGVNVsALSRDIKWDFTPCKNLRVGS |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38936 | S130 | SIGNOR|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | HVDLsLSCTLVPRsGEQAEGsPGGPGDSQGRKRRQtsMTDF |
| P38936 | S98 | PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LPtGPRRGRDELGGGRRPGtsPALLQGTAEEDHVDLsLSCT |
| P38936 | T57 | PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LMAGCIQEARERWNFDFVtEtPLEGDFAWERVRGLGLPKLy |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P40222 | S515 | Sugiyama | TXLNA TXLN | sLtDsGPERRPEGPGAQAPssPRVtEAPCyPGAPSTEASGQ |
| P40763 | S727 | SIGNOR|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P40939 | T395 | Sugiyama | HADHA HADH | GIAQVSVDKGLKTILKDAtLtALDRGQQQVFKGLNDKVKKK |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41212 | S22 | PSP | ETV6 TEL TEL1 | SEtPAQCSIKQERIsytPPEsPVPsyAsstPLHVPVPRALR |
| P41212 | S257 | PSP | ETV6 TEL TEL1 | VSPMENNHCPASSESHPKPSsPRQESTRVIQLMPsPIMHPL |
| P41235 | S167 | SIGNOR|iPTMNet|PSP | HNF4A HNF4 NR2A1 TCF14 | ssLPsINALLQAEVLSRQItsPVSGINGDIRAKKIASIADV |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P41970 | S357 | SIGNOR | ELK3 NET SAP2 | NGLLLTPSPLLSSIHFWSSLsPVAPLsPARLQGPSTLFQFP |
| P41970 | S363 | SIGNOR|iPTMNet | ELK3 NET SAP2 | PSPLLSSIHFWSSLsPVAPLsPARLQGPSTLFQFPTLLNGH |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42224 | S727 | GPS6|SIGNOR|PSP | STAT1 | IsVsEVHPSRLQttDNLLPMsPEEFDEVSRIVGsVEFDSMM |
| P42566 | S796 | SIGNOR|PSP | EPS15 AF1P | GtPTRPCPLPPGKRsINKLDsPDPFKLNDPFQPFPGNDsPK |
| P42566 | S814 | Sugiyama | EPS15 AF1P | LDsPDPFKLNDPFQPFPGNDsPKEKDPEIFCDPFTSATTTT |
| P42574 | S150 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CASP3 CPP32 | TNGPVDLKKITNFFRGDRCRsLtGKPKLFIIQACRGTELDC |
| P42677 | S27 | PSP | RPS27 MPS1 | LLHPsPEEEKRKHKKKRLVQsPNsyFMDVKCPGCYKITTVF |
| P43121 | T107 | Sugiyama | MCAM MUC18 | EYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKRPRSQEYR |
| P43403 | T293 | SIGNOR|PSP | ZAP70 SRK | HPSTLTHPQRRIDtLNsDGytPEPARItsPDKPRPMPMDts |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46940 | T1410 | Sugiyama | IQGAP1 KIAA0051 | RLIVDVIRFQPGETLtEILEtPAtsEQEAEHQRAMQRRAIR |
| P46940 | T1413 | Sugiyama | IQGAP1 KIAA0051 | VDVIRFQPGETLtEILEtPAtsEQEAEHQRAMQRRAIRDAK |
| P47712 | S505 | SIGNOR|iPTMNet | PLA2G4A CPLA2 PLA2G4 | RAGKVHNFMLGLNLNTSYPLsPLSDFATQDsFDDDELDAAV |
| P48436 | S211 | PSP | SOX9 | EATEQtHIsPNAIFKALQADsPHsSSGMSEVHsPGEHsGQs |
| P48741 | T224 | Sugiyama | HSPA7 HSP70B | GGTFDVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFM |
| P49023 | S106 | Sugiyama | PXN | PVyGssAKtssVsNPQDsVGsPCsRVGEEEHVysFPNKQKs |
| P49023 | S85 | SIGNOR|PSP | PXN | PLDQWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVG |
| P49137 | S272 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPKAPK2 | IMYILLCGYPPFYSNHGLAIsPGMKTRIRMGQYEFPNPEWS |
| P49137 | T206 | SIGNOR|iPTMNet | MAPKAPK2 | DVKPENLLYtSKRPNAILKLtDFGFAKEttsHNsLttPCyt |
| P49137 | T222 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPKAPK2 | ILKLtDFGFAKEttsHNsLttPCytPyyVAPEVLGPEKYDK |
| P49137 | T25 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPKAPK2 | SQGQsPPVPFPAPAPPPQPPtPALPHPPAQPPPPPPQQFPQ |
| P49137 | T317 | SIGNOR|iPTMNet | MAPKAPK2 | EVKMLIRNLLKTEPTQRMTItEFMNHPWIMQSTKVPQtPLH |
| P49137 | T334 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPKAPK2 | MTItEFMNHPWIMQSTKVPQtPLHtsRVLKEDKERWEDVKE |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49321 | T390 | Sugiyama | NASP | EAPVLPKDGAVNGPsVVGDQtPIEPQtsIERLtEtKDGsGL |
| P49327 | S831 | Sugiyama | FASN FAS | NPNALFPPVEFPAPRGtPLIsPLIKWDHSLAWDVPAAEDFP |
| P49327 | T827 | Sugiyama | FASN FAS | GIDANPNALFPPVEFPAPRGtPLIsPLIKWDHSLAWDVPAA |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P49411 | T74 | Sugiyama | TUFM | YVRDKPHVNVGTIGHVDHGKtTLTAAITKILAEGGGAKFKK |
| P49753 | S360 | Sugiyama | ACOT2 PTE2 PTE2A | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| P49792 | S1764 | Sugiyama | RANBP2 NUP358 | CIACQCPSKQNQtTAIstPAssEIsKAPKsGFEGMFIRKGQ |
| P49792 | S1894 | Sugiyama | RANBP2 NUP358 | FQGSSNTEFKSTKEGFSIPVsADGFKFGIsEPGNQEKKSEK |
| P49792 | T1146 | Sugiyama | RANBP2 NUP358 | RRsDDMFTFHGPGKsVFGtPtLETANKNHEtDGGsAHGDDD |
| P49841 | S389 | SIGNOR|PSP | GSK3B | SNPPLATILIPPHARIQAAAstPtNATAASDANTGDRGQTN |
| P49841 | T390 | PSP | GSK3B | NPPLATILIPPHARIQAAAstPtNATAASDANTGDRGQTNN |
| P49841 | T43 | PSP | GSK3B | FGsMKVSRDKDGSKVTTVVAtPGQGPDRPQEVSyTDTKVIG |
| P50395 | S316 | Sugiyama | GDI2 RABGDIB | QVIRVICILSHPIKNtNDANsCQIIIPQNQVNRKSDIyVCM |
| P50395 | S43 | Sugiyama | GDI2 RABGDIB | MSVNGKKVLHMDRNPyyGGEsAsItPLEDLyKRFKIPGsPP |
| P50395 | T394 | Sugiyama | GDI2 RABGDIB | EPIEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttC |
| P50395 | T47 | Sugiyama | GDI2 RABGDIB | GKKVLHMDRNPyyGGEsAsItPLEDLyKRFKIPGsPPEsMG |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50990 | T331 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | MLVRLNSKWDLRRLCKtVGAtALPRLTPPVLEEMGHCDSVY |
| P51149 | S72 | PSP | RAB7A RAB7 | VDDRLVTMQIWDTAGQERFQsLGVAFYRGADCCVLVFDVTA |
| P52594 | S368 | Sugiyama | AGFG1 HRB RAB RIP | GFGTTGKAPVGsVVsVPsQssAssDKYAALAELDSVFSSAA |
| P52597 | S104 | Sugiyama | HNRNPF HNRPF | EVFKSHRTEMDWVLKHsGPNsADsANDGFVRLRGLPFGCTK |
| P52888 | S29 | Sugiyama | THOP1 | GDMADAAsPCSVVNDLRWDLsAQQIEERTRELIEQTKRVyD |
| P52945 | S61 | PSP | PDX1 IPF1 STF1 | QPPPPPPHPFPGALGALEQGsPPDIsPYEVPPLADDPAVAH |
| P52945 | S66 | PSP | PDX1 IPF1 STF1 | PPHPFPGALGALEQGsPPDIsPYEVPPLADDPAVAHLHHHL |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53396 | S481 | Sugiyama | ACLY | ADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTKAIV |
| P53667 | S310 | PSP | LIMK1 LIMK | QKPVLRsCsIDRsPGAGsLGsPAsQRKDLGRSEsLRVVCRP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S224 | Sugiyama | HSPA2 | GGGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHL |
| P54652 | T225 | Sugiyama | HSPA2 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55060 | T341 | Sugiyama | CSE1L CAS XPO2 | LASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEA |
| P55273 | S66 | PSP | CDKN2D | LQVMMFGSTAIALELLKQGAsPNVQDTSGTsPVHDAARTGF |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55795 | T107 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | KSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSKEEI |
| P56178 | S34 | SIGNOR | DLX5 | SGDFQAPFQTSAAMHHPSQEsPTLPESSATDSDYYSPTGGA |
| P56817 | S83 | PSP | BACE1 BACE KIAA1149 | MVDNLRGKSGQGYYVEMTVGsPPQTLNILVDTGSSNFAVGA |
| P60174 | S80 | Sugiyama | TPI1 TPI | IAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGHsERR |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T76 | Sugiyama | TPI1 TPI | LDPKIAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGH |
| P60228 | S442 | Sugiyama | EIF3E EIF3S6 INT6 | IEKKLNQNSRSEAPNWAtQDsGFy_________________ |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61371 | S269 | PSP | ISL1 | QQPNDKTNIQGMtGtPMVAAsPERHDGGLQANPVEVQSYQP |
| P61586 | S160 | Sugiyama | RHOA ARH12 ARHA RHO12 | KPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtRAALQ |
| P61604 | S21 | Sugiyama | HSPE1 | MAGQAFRKFLPLFDRVLVERsAAETVTKGGIMLPEKSQGKV |
| P61758 | T45 | Sugiyama | VBP1 PFDN3 | IPEAVFVEDVDSFMKQPGNEtADtVLKKLDEQYQKYKFMEL |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S81 | Sugiyama | HNRNPK HNRPK | GGKNIKALRtDyNAsVsVPDssGPERILsISADIETIGEIL |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62826 | S150 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARKLIG |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62829 | S115 | Sugiyama | RPL23 | FLYFEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASN |
| P62829 | T118 | Sugiyama | RPL23 | FEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASNAGs |
| P62899 | T59 | Sugiyama | RPL31 | KKRAPRALKEIRKFAMKEMGtPDVRIDTRLNKAVWAKGIRN |
| P62913 | T44 | Sugiyama | RPL11 | ICVGEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRR |
| P62913 | T47 | Sugiyama | RPL11 | GEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEK |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T229 | Sugiyama | YWHAZ | EsyKDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN____ |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | S11 | SIGNOR | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P78356 | S326 | SIGNOR|PSP | PIP4K2B PIP5K2B | ECENDGVGGNLLCsyGtPPDsPGNLLSFPRFFGPGEFDPSV |
| P78371 | S143 | Sugiyama | CCT2 99D8.1 CCTB | PQTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIA |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78371 | T475 | Sugiyama | CCT2 99D8.1 CCTB | GYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGITE |
| P78527 | T2645 | Sugiyama | PRKDC HYRC HYRC1 | LSARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstD |
| P78527 | T2647 | Sugiyama | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| P78527 | T2649 | Sugiyama | PRKDC HYRC HYRC1 | WPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPLVD |
| P78536 | T735 | SIGNOR|PSP | ADAM17 CSVP TACE | MLSSMDSASVRIIKPFPAPQtPGRLQPAPVIPSAPAAPKLD |
| P78543 | S149 | GPS6 | BTG2 PC3 | AASCGLLTCKNQVLLGRssPsKNYVMAVSS___________ |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84022 | S204 | SIGNOR | SMAD3 MADH3 | YLSEDGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPV |
| P84022 | S208 | SIGNOR|iPTMNet | SMAD3 MADH3 | DGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCE |
| P84022 | S213 | iPTMNet | SMAD3 MADH3 | DHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCEPAFWC |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| P85037 | T422 | Sugiyama | FOXK1 MNF | VSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsR |
| P85037 | T436 | Sugiyama | FOXK1 MNF | sAPAsPtHPGLMsPRsGGLQtPECLsREGsPIPHDPEFGsK |
| P98082 | T638 | Sugiyama | DAB2 DOC2 | TPPQPPPRAGPPKDIssDAFtALDPLGDKEIKDVKEMFKDF |
| Q00610 | S886 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | IHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsRVVG |
| Q00613 | S303 | PSP | HSF1 HSTF1 | SIDERPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDt |
| Q00613 | S307 | PSP|Sugiyama | HSF1 HSTF1 | RPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDtLLsP |
| Q00613 | S326 | PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01130 | S212 | Sugiyama | SRSF2 SFRS2 | PPPVsKRESKSRSRsKsPPKsPEEEGAVss___________ |
| Q01433 | S97 | Sugiyama | AMPD2 | FTRSLAESELRSAPYEFPEEsPIEQLEERRQRLERQISQDV |
| Q01484 | Y945 | Sugiyama | ANK2 ANKB | SVVIPSHQVSTLAKEAERNsyRLSWGTENLDNVALSSSPIH |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01844 | T422 | Sugiyama | EWSR1 EWS | LDKETGKPKGDATVSyEDPPtAKAAVEWFDGKDFQGSKLKV |
| Q01844 | T79 | SIGNOR|PSP | EWSR1 EWS | ATYGQTAYATSYGQPPTGYttPtAPQAYSQPVQGYGTGAYD |
| Q02078 | S192 | PSP | MEF2A MEF2 | STLTDSSMLSPPQTTLHRNVsPGAPQRPPstGNAGGMLstt |
| Q02078 | S223 | PSP | MEF2A MEF2 | GNAGGMLsttDLtVPNGAGssPVGNGFVNSRAsPNLIGATG |
| Q02078 | S255 | GPS6 | MEF2A MEF2 | sPNLIGATGANSLGKVMPtKsPPPPGGGNLGMNSRKPDLRV |
| Q02078 | S408 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | QGSNLSINTNQNISIKSEPIsPPRDRMTPSGFQQQQQQQQQ |
| Q02078 | S453 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | MEF2A MEF2 | PPPQPQPQPPQPQPRQEMGRsPVDSLSSSSSSYDGSDREDP |
| Q02078 | S479 | PSP | MEF2A MEF2 | SSSSSSYDGSDREDPRGDFHsPIVLGRPPNtEDREsPSVKR |
| Q02078 | S494 | PSP | MEF2A MEF2 | RGDFHsPIVLGRPPNtEDREsPSVKRMRMDAWVT_______ |
| Q02078 | S98 | PSP | MEF2A MEF2 | SRTNSDIVEALNKKEHRGCDsPDPDtsyVLtPHTEEKYKKI |
| Q02078 | T108 | PSP | MEF2A MEF2 | LNKKEHRGCDsPDPDtsyVLtPHTEEKYKKINEEFDNMMRN |
| Q02078 | T312 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | EELELNTQRISSSQATQPLAtPVVSVTtPSLPPQGLVYSAM |
| Q02078 | T319 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | QRISSSQATQPLAtPVVSVTtPSLPPQGLVYSAMPTAYNTD |
| Q02156 | S350 | PSP | PRKCE PKCE | PQPAsGssPsEEDRsKsAPtsPCDQEIKELENNIRKALsFD |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q02952 | S286 | Sugiyama | AKAP12 AKAP250 | KEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQGWAG |
| Q04206 | S536 | EPSD | RELA NFKB3 | APLGAPGLPNGLLsGDEDFSsIADMDFsALLSQISS_____ |
| Q04637 | S1118 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | sGGSGAKPSDAAsEAARPAtstLNRFsALQQAVPtEsTDNR |
| Q04721 | S838 | Sugiyama | NOTCH2 | TCHCVLPYTGKNCQTVLAPCsPNPCENAAVCKESPNFESYT |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q06210 | S37 | Sugiyama | GFPT1 GFAT GFPT | REILETLIKGLQRLEYRGYDsAGVGFDGGNDKDWEANACKI |
| Q06330 | T339 | SIGNOR|PSP | RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH | KEMINDGASWTIISTDKAEYtFYEGMGPVLAPVTPVPVVES |
| Q06413 | S387 | SIGNOR | MEF2C | GACTSTHLSQSSNLSLPSTQsLNIKSEPVsPPRDRTTtPSR |
| Q06413 | T293 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2C | DVDLLLNQRINNSQSAQSLAtPVVSVAtPTLPGQGMGGYPS |
| Q06413 | T300 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2C | QRINNSQSAQSLAtPVVSVAtPTLPGQGMGGYPSAISTTYG |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07021 | T163 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | FDGEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALV |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07157 | S1617 | Sugiyama | TJP1 ZO1 | AEKPKyQINNISTVPKAIPVsPsAVEEDEDEDGHTVVATAR |
| Q07666 | S58 | GPS6|ELM|iPTMNet|EPSD | KHDRBS1 SAM68 | PPLPHRSRGGGGGSRGGARAsPAtQPPPLLPPSAtGPDATV |
| Q07666 | T84 | GPS6|ELM|iPTMNet|EPSD | KHDRBS1 SAM68 | PPLLPPSAtGPDATVGGPAPtPLLPPSATASVKMEPENKyL |
| Q07817 | S62 | PSP | BCL2L1 BCL2L BCLX | ESEMEtPsAINGNPSWHLADsPAVNGATGHSSSLDAREVIP |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q09666 | T3716 | Sugiyama | AHNAK PM227 | VEGDLKGPEVDIKGPKVDIDtPDINIEGsEGKFKGPKFKIP |
| Q09666 | T4564 | Sugiyama | AHNAK PM227 | LEGDLKGPKVDVKGPKVGIDtPDIDIHGPEGKLKGPKFKMP |
| Q12765 | T297 | Sugiyama | SCRN1 KIAA0193 | SGVSVLPQNRSSPCIHyFtGtPDPSRSIFKPFIFVDDVKLV |
| Q12765 | Y293 | Sugiyama | SCRN1 KIAA0193 | LTTASGVSVLPQNRSSPCIHyFtGtPDPSRSIFKPFIFVDD |
| Q12774 | S445 | Sugiyama | ARHGEF5 TIM | ASYLMTQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISL |
| Q12774 | S450 | Sugiyama | ARHGEF5 TIM | TQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISLLGsFL |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q12792 | T148 | Sugiyama | TWF1 PTK9 | DVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQtDVGV |
| Q12888 | T1609 | SIGNOR | TP53BP1 | SLEQGNRLREQYGLGPYEAVtPLtKAADIsLDNLVEGKRKR |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q12948 | S241 | SIGNOR|PSP | FOXC1 FKHL7 FREAC3 | VRIQDIKtENGtCPsPPQPLsPAAALGsGsAAAVPKIEsPD |
| Q12948 | S272 | SIGNOR|PSP | FOXC1 FKHL7 FREAC3 | AAVPKIEsPDsSsSSLSsGssPPGSLPSARPLSLDGADSAP |
| Q13033 | S229 | Sugiyama | STRN3 GS2NA SG2NA | SEPNGsVETKNLEQILNGGEsPKQKGQEIKRSSGDVLETFN |
| Q13155 | S156 | PSP | AIMP2 JTV1 PRO0992 | LVLHRLLCEHFRVLSTVHTHsSVKSVPENLLKCFGEQNKKQ |
| Q13263 | S473 | PSP | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13263 | S757 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKLTE |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13309 | S64 | PSP | SKP2 FBXL1 | EEPDsENIPQELLsNLGHPEsPPRKRLKsKGsDKDFVIVRR |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13501 | S266 | Sugiyama | SQSTM1 ORCA OSIL | AALsPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQP |
| Q13501 | S272 | Sugiyama | SQSTM1 ORCA OSIL | GIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssCCsD |
| Q13501 | T269 | Sugiyama | SQSTM1 ORCA OSIL | sPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssC |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S172 | Sugiyama | TUBB3 TUBB4 | ISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSIHQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13526 | S115 | Sugiyama | PIN1 | KIKSGEEDFEsLAsQFSDCSsAKARGDLGAFsRGQMQKPFE |
| Q13541 | S65 | SIGNOR|iPTMNet | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13541 | T37 | SIGNOR|iPTMNet | EIF4EBP1 | ATRRVVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDRK |
| Q13541 | T46 | SIGNOR|iPTMNet | EIF4EBP1 | GVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRNsP |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S477 | Sugiyama | UBAP2L KIAA0144 NICE4 | PsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKKAsLTSK |
| Q14160 | S1448 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | QEDEQPPWAsPsPtsRQsPAsPPPLGGGAPVRTAKAERRHQ |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14444 | T306 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEVVNS |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14697 | T204 | Sugiyama | GANAB G2AN KIAA0088 | PRVsQGsKDPAEGDGAQPEEtPRDGDKPEETQGKAEKDEPG |
| Q14721 | S800 | PSP | KCNB1 | GStsPKFSTGTRSEKNHFESsPLPtsPKFLRQNCIYSTEAL |
| Q14721 | S805 | PSP | KCNB1 | KFSTGTRSEKNHFESsPLPtsPKFLRQNCIYSTEALTGKGP |
| Q14765 | S721 | GPS6|SIGNOR|iPTMNet | STAT4 | ISTIRSDSTEPHsPSDLLPMsPSVYAVLRENLsPTTIETAM |
| Q14790 | S347 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CASP8 MCH5 | DGQEAPIyELTSQFTGLKCPsLAGKPKVFFIQACQGDNYQK |
| Q14934 | S168 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFATC4 NFAT3 | PPEGFGGYREAGGQGGGAFFsPsPGSSSLSSWSFFSDASDE |
| Q14934 | S170 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFATC4 NFAT3 | EGFGGYREAGGQGGGAFFsPsPGSSSLSSWSFFSDASDEAA |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15046 | S49 | PSP | KARS1 KARS KIAA0070 | AEKKVAEKEAKQKELSEKQLsQAtAAATNHTTDNGVGPEEE |
| Q15046 | T52 | PSP | KARS1 KARS KIAA0070 | KVAEKEAKQKELSEKQLsQAtAAATNHTTDNGVGPEEESVD |
| Q15075 | T1392 | SIGNOR|iPTMNet|PSP | EEA1 ZFYVE2 | HHCRQCGNIFCAECSAKNALtPSSKKPVRVCDACFNDLQG_ |
| Q15084 | S248 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | LAsRYGIRGFPtIKIFQKGEsPVDyDGGRTRsDIVsRALDL |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15181 | S250 | Sugiyama | PPA1 IOPPP PP | LVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPPPC |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15181 | T246 | Sugiyama | PPA1 IOPPP PP | HWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDAL |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15365 | S190 | Sugiyama | PCBP1 | LsQsPQGRVMtIPyQPMPAssPVICAGGQDRCsDAAGYPHA |
| Q15599 | S43 | Sugiyama | NHERF2 SLC9A3R2 | FHLHGEKGRRGQFIRRVEPGsPAEAAALRAGDRLVEVNGVN |
| Q15642 | S298 | Sugiyama | TRIP10 CIP4 STOT STP | RPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRT |
| Q15672 | S68 | SIGNOR|PSP | TWIST1 BHLHA38 TWIST | GGAGPGGAAGGGVGGGDEPGsPAQGKRGKKSAGCGGGGGAG |
| Q15717 | S88 | PSP | ELAVL1 HUR | yVTAKDAERAINTLNGLRLQsKTIKVSYARPssEVIKDANL |
| Q15717 | T118 | SIGNOR|PSP | ELAVL1 HUR | PssEVIKDANLyISGLPRTMtQKDVEDMFSRFGRIINSRVL |
| Q15746 | S947 | PSP | MYLK MLCK MLCK1 MYLK1 | ANLQRQVKPKTVSEEERKVHsPQQVDFRSVLAKKGTSKTPV |
| Q15746 | T978 | PSP | MYLK MLCK MLCK1 MYLK1 | AKKGTSKTPVPEKVPPPKPAtPDFRSVLGGKKKLPAENGSS |
| Q15750 | S378 | Sugiyama | TAB1 MAP3K7IP1 | MTLLVRNFGYPLGEMSQPtPsPAPAAGGRVYPVSVPYSSAQ |
| Q15750 | S423 | SIGNOR|ELM|iPTMNet|EPSD|PSP | TAB1 MAP3K7IP1 | TSVTLSLVMPSQGQMVNGAHsASTLDEAtPTLTNQsPTLTL |
| Q15750 | S438 | SIGNOR|ELM|iPTMNet|EPSD|PSP | TAB1 MAP3K7IP1 | VNGAHsASTLDEAtPTLTNQsPTLTLQSTNTHTQssSSssD |
| Q15750 | S452 | PSP | TAB1 MAP3K7IP1 | PTLTNQsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPP |
| Q15750 | S453 | PSP | TAB1 MAP3K7IP1 | TLTNQsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPPG |
| Q15750 | S456 | PSP | TAB1 MAP3K7IP1 | NQsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPPGEDG |
| Q15750 | S457 | PSP | TAB1 MAP3K7IP1 | QsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPPGEDGR |
| Q15750 | T376 | Sugiyama | TAB1 MAP3K7IP1 | EDMTLLVRNFGYPLGEMSQPtPsPAPAAGGRVYPVSVPYSS |
| Q15750 | T431 | SIGNOR|ELM|iPTMNet|EPSD|PSP | TAB1 MAP3K7IP1 | MPSQGQMVNGAHsASTLDEAtPTLTNQsPTLTLQSTNTHTQ |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q15910 | T367 | SIGNOR|PSP | EZH2 KMT6 | PKRPGGRRRGRLPNNssRPstPtINVLEsKDtDsDREAGtE |
| Q16204 | S240 | Sugiyama | CCDC6 D10S170 TST1 | RMDKLEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMR |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16539 | S143 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | tDDHVQFLIYQILRGLKYIHsADIIHRDLKPsNLAVNEDCE |
| Q16539 | S154 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | ILRGLKYIHsADIIHRDLKPsNLAVNEDCELKILDFGLARH |
| Q16539 | S261 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | TPGAELLKKISSESARNYIQsLtQMPKMNFANVFIGANPLA |
| Q16539 | S28 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | FYRQELNKTIWEVPERYQNLsPVGsGAYGSVCAAFDTKTGL |
| Q16539 | S32 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | ELNKTIWEVPERYQNLsPVGsGAYGSVCAAFDTKTGLRVAV |
| Q16539 | T180 | GPS6|EPSD|Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | EDCELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHY |
| Q16539 | T263 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | GAELLKKISSESARNYIQsLtQMPKMNFANVFIGANPLAVD |
| Q16539 | Y182 | Sugiyama | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | CELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHYNQ |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16630 | T404 | Sugiyama | CPSF6 CFIM68 | yGRPPPYDRGDyGPPGREMDtARtPLsEAEFEEIMNRNRAI |
| Q16630 | T407 | Sugiyama | CPSF6 CFIM68 | PPPYDRGDyGPPGREMDtARtPLsEAEFEEIMNRNRAISSS |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q53EL6 | T90 | Sugiyama | PDCD4 H731 | DsGRGDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGR |
| Q53EL6 | T93 | Sugiyama | PDCD4 H731 | RGDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLP |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T34 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | KEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTITKSE |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6FI81 | T136 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CSALTLSGLVEVKELQREPLtPEEVQSVREHLGHESDNLLF |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z3J3 | S919 | Sugiyama | RGPD4 RGP4 | tKGSSNTEFKSTKEGFSIPVsADGFKFGIsEPGNQEKESEK |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z6M1 | S137 | Sugiyama | RABEPK RAB9P40 | QVLNPETRTWTTPEVtsPPPsPRTFHTSSAAIGNQLYVFGG |
| Q7Z6M1 | T132 | Sugiyama | RABEPK RAB9P40 | NRNCLQVLNPETRTWTTPEVtsPPPsPRTFHTSSAAIGNQL |
| Q86TX2 | S298 | Sugiyama | ACOT1 CTE1 | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| Q86UR1 | S239 | PSP | NOXA1 P51NOX | RPQQPQGPGANHDARSLIMDsPRAGTHQGPLDAETEVGADR |
| Q86UR1 | S282 | PSP | NOXA1 P51NOX | STAYQEQRPQVEQVGKQAPLsPGLPAMGGPGPGPCEDPAGA |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IW41 | T182 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPKAPK5 PRAK | DAPVKLCDFGFAKIDQGDLMtPQFtPyYVAPQVLEAQRRHQ |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N0Y7 | T96 | Sugiyama | PGAM4 PGAM3 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| Q8N1F7 | S112 | Sugiyama | NUP93 KIAA0095 | PVKDTDIQGFLKNEKDNALLsAIEESRKRtFGMAEEYHRES |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N556 | S668 | Sugiyama | AFAP1 AFAP | AGGVTLGLAIEPKsGtssPQsPVFRHRtLENsPIssCDtsD |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S281 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | ADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8NBS9 | S125 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KYNSMEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPG |
| Q8NBS9 | S129 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | MEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPGQEAV |
| Q8NBS9 | S255 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | EHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDGKKVD |
| Q8NBS9 | T122 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | LGDKYNSMEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLF |
| Q8ND56 | S300 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GRFGIRRDGPMKFEKDFDFEsANAQFNKEEIDREFHNKLKL |
| Q8NDV7 | S1047 | Sugiyama | TNRC6A CAGH26 KIAA1460 TNRC6 | PNGNSRSDQQAQVHQLLtPAsAISNKEASSGSGWGEPWGEP |
| Q8NDV7 | T1044 | Sugiyama | TNRC6A CAGH26 KIAA1460 TNRC6 | KNVPNGNSRSDQQAQVHQLLtPAsAISNKEASSGSGWGEPW |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8NHW3 | S14 | iPTMNet | MAFA | _______MAAELAMGAELPSsPLAIEYVNDFDLMKFEVKKE |
| Q8NHW3 | T134 | PSP | MAFA | EDLYWMSGYQHHLNPEALNLtPEDAVEALIGSGHHGAHHGA |
| Q8NHW3 | T57 | PSP | MAFA | EAERFCHRLPPGsLSStPLStPCSsVPSsPSFCAPSPGTGG |
| Q8TAQ2 | S283 | Sugiyama | SMARCC2 BAF170 | KNPVSRRKKISAKtLtDEVNsPDsDRRDKKGGNYKKRKRsP |
| Q8TE85 | T454 | PSP | GRHL3 SOM TFCP2L4 | LLSGFRGNETTYLRPETDLEtPPVLFIPNVHFSSLQRSGGA |
| Q8WW12 | S142 | Sugiyama | PCNP | EEMPPEAKMRMKNIGRDtPtsAGPNsFNKGKHGFsDNQKLW |
| Q8WW12 | T139 | Sugiyama | PCNP | sEPEEMPPEAKMRMKNIGRDtPtsAGPNsFNKGKHGFsDNQ |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q8WYK2 | T148 | SIGNOR|iPTMNet|PSP | JDP2 | LILMLNRHRPTCIVRTDsVKtPEsEGNPLLEQLEKK_____ |
| Q92530 | S152 | Sugiyama | PSMF1 | SRIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIP |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92530 | T162 | Sugiyama | PSMF1 | IHEQWEKANVssPHREFPPAtAREVDPLRIPPHHPHTSRQP |
| Q92609 | S539 | Sugiyama | TBC1D5 KIAA0210 | KsEsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssA |
| Q92620 | T265 | Sugiyama | DHX38 DDX38 KIAA0224 PRP16 | SHRLSTRDRDRSVRGKYSDDtPLPtPSYKYNEWADDRRHLG |
| Q92620 | T269 | Sugiyama | DHX38 DDX38 KIAA0224 PRP16 | STRDRDRSVRGKYSDDtPLPtPSYKYNEWADDRRHLGSTPR |
| Q92804 | S295 | Sugiyama | TAF15 RBP56 TAF2N | TDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFHGNIIKV |
| Q92879 | S179 | Sugiyama | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92934 | S75 | EPSD | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92945 | S181 | Sugiyama | KHSRP FUBP2 | GRGGEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsV |
| Q92945 | T100 | Sugiyama | KHSRP FUBP2 | RARQIAAKIGGDAAttVNNstPDFGFGGQKRQLEDGDQPEs |
| Q92945 | T692 | SIGNOR|PSP | KHSRP FUBP2 | PDYSAAWAEYYRQQAAyYGQtPGPGGPQPPPTQQGQQQAQ_ |
| Q92945 | T94 | Sugiyama | KHSRP FUBP2 | FADAVQRARQIAAKIGGDAAttVNNstPDFGFGGQKRQLED |
| Q92993 | T158 | PSP | KAT5 HTATIP TIP60 | SCLQPNHRSTKRKVEVVsPAtPVPSETAPASVFPQNGAARR |
| Q969V6 | S312 | PSP | MRTFA KIAA1438 MAL MKL1 | PPKSAGEALGSsGtPPVRsLsttNSSSSsGAPGPCGLARQN |
| Q969V6 | S333 | PSP | MRTFA KIAA1438 MAL MKL1 | ttNSSSSsGAPGPCGLARQNstsLtGKPGALPANLDDMKVA |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96G46 | S277 | Sugiyama | DUS3L | QENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRLRPCE |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96I25 | S222 | PSP | RBM17 SPF45 | sQsSKAAIPPPVyEEQDRPRsPtGPsNsFLANMGGTVAHKI |
| Q96I25 | T71 | PSP | RBM17 SPF45 | LAPVIDLKRGGssDDRQIVDtPPHVAAGLKDPVPSGFSAGE |
| Q96IR7 | S365 | Sugiyama | HPDL GLOXD1 | GATGFGQGNIRALWQsVQEQsARSQEA______________ |
| Q96L92 | S51 | PSP | SNX27 KIAA0488 My014 | AGNGGGGGGGPRVVRIVKsEsGYGFNVRGQVsEGGQLRSIN |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96NT5 | S458 | Sugiyama | SLC46A1 G21 HCP1 PCFT | VLIGMLEKADPHLEFQQFPQsP___________________ |
| Q96QK1 | S786 | Sugiyama | VPS35 MEM3 TCCCTA00141 | INKHFHNtLEHLRLRREsPEsEGPIyEGLIL__________ |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99626 | S283 | SIGNOR|PSP | CDX2 CDX3 | PPPQPPQPQPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPT |
| Q99626 | S287 | SIGNOR | CDX2 CDX3 | PPQPQPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVL |
| Q99626 | S291 | SIGNOR | CDX2 CDX3 | QPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVLNPTV |
| Q99626 | S295 | SIGNOR | CDX2 CDX3 | LRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVLNPTVTQ__ |
| Q99666 | S918 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | tKGSSNTEFKSTKEGFSIPVsADGFKFGIsEPGNQEKKREK |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99733 | T51 | Sugiyama | NAP1L4 NAP2 | VMQNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALK |
| Q99958 | S367 | PSP | FOXC2 FKHL14 MFH1 | HMCVPPALDEALSDHPSGPTsPLSALNLAAGQEGALAATGH |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BR76 | S2 | PSP | CORO1B | ___________________MsFRKVVRQSKFRHVFGQPVKN |
| Q9BUB5 | T250 | SIGNOR|PSP | MKNK1 MNK1 | ICDFDLGSGMKLNNSCTPITtPELTtPCGSAEYMAPEVVEV |
| Q9BUB5 | T255 | SIGNOR|PSP | MKNK1 MNK1 | LGSGMKLNNSCTPITtPELTtPCGSAEYMAPEVVEVFTDQA |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9C000 | S107 | PSP | NLRP1 CARD7 DEFCAP KIAA0926 NAC NALP1 | QEGAGHSPSFPYSPSEPHLGsPSQPTSTAVLMPWIHELPAG |
| Q9C026 | S76 | PSP | TRIM9 KIAA0282 RNF91 | GVSDyDYLDLDKMSLYSEADsGYGsYGGFASAPTTPCQKSP |
| Q9C026 | S80 | PSP | TRIM9 KIAA0282 RNF91 | yDYLDLDKMSLYSEADsGYGsYGGFASAPTTPCQKSPNGVR |
| Q9C0C2 | S1029 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LGEGsRDAGRPGERGsGGLFsPstAHVPDGALGQRDQssWQ |
| Q9C0C2 | S1031 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EGsRDAGRPGERGsGGLFsPstAHVPDGALGQRDQssWQNs |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S1297 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GQADWtPDLGLRNMAPGAVCsPGEsKELGVGQMDWGNNLGL |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | T715 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEFGIT |
| Q9GZY8 | S155 | PSP | MFF C2orf33 AD030 AD033 GL004 | PPttPQNEEIRAVGRLKRERsMsENAVRQNGQLVRNDsLWH |
| Q9H0B6 | S445 | Sugiyama | KLC2 | RRDsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKL |
| Q9H1K0 | S215 | SIGNOR|iPTMNet|PSP | RBSN ZFYVE20 | SLPLANKLTSASKEsLstHtsPsQsPNsVHGsRRGsIssMs |
| Q9H211 | S391 | SIGNOR|PSP | CDT1 | IsPRMEKALsQLALRsAAPssPGsPRPALPAtPPAtPPAAs |
| Q9H211 | S411 | PSP | CDT1 | sPGsPRPALPAtPPAtPPAAsPSALKGVSQDLLERIRAKEA |
| Q9H211 | S491 | SIGNOR|PSP | CDT1 | PALSMEVACARMVGSCCTIMsPGEMEKHLLLLSELLPDWLS |
| Q9H211 | T402 | PSP | CDT1 | LALRsAAPssPGsPRPALPAtPPAtPPAAsPSALKGVSQDL |
| Q9H211 | T406 | PSP | CDT1 | sAAPssPGsPRPALPAtPPAtPPAAsPSALKGVSQDLLERI |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H3D4 | S160 | PSP | TP63 KET P63 P73H P73L TP73L | QNSVTAPSPyAQPSSTFDALsPsPAIPSNTDyPGPHSFDVS |
| Q9H3D4 | S162 | PSP | TP63 KET P63 P73H P73L TP73L | SVTAPSPyAQPSSTFDALsPsPAIPSNTDyPGPHSFDVSFQ |
| Q9H3D4 | S310 | SIGNOR | TP63 KET P63 P73H P73L TP73L | yEPPQVGTEFTTVLYNFMCNsSCVGGMNRRPILIIVTLETR |
| Q9H3D4 | S395 | PSP | TP63 KET P63 P73H P73L TP73L | KRPFRQNTHGIQMTsIKKRRsPDDELLYLPVRGRETYEMLL |
| Q9H3D4 | S455 | PSP | TP63 KET P63 P73H P73L TP73L | YRQQQQQQHQHLLQKQTsIQsPssYGNssPPLNKMNSMNKL |
| Q9H3K6 | T76 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | VNACLAEELPHIHAFEQKTLtPDQWARERQK__________ |
| Q9H3M7 | S361 | PSP | TXNIP VDUP1 | DHRLESPttPLLDDMDGsQDsPIFMYAPEFKFMPPPtytEV |
| Q9H488 | S264 | Sugiyama | POFUT1 FUT12 KIAA0180 | DWKNACAMLKDGTAGSHFMAsPQCVGySRSTAAPLTMTMCL |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S80 | Sugiyama | CCDC86 CYCLON | ERPPKtsPGsPRLQQGAGLEsPQGQPEPGAAsPQRQQDLHL |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9H8Y8 | S436 | Sugiyama | GORASP2 GOLPH6 | PPtAKAPttVEDRVGDstPVsEKPVsAAVDANAsEsP____ |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9HCD6 | S169 | Sugiyama | TANC2 KIAA1148 KIAA1636 | tLPPISTNATAKDCSyGAVtsPtstLESRDSGIIATLTSYS |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQR4 | S207 | Sugiyama | NIT2 CUA002 | HWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHSTVVNP |
| Q9NQR4 | T205 | Sugiyama | NIT2 CUA002 | PAHWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHSTVV |
| Q9NQU5 | S165 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PAK6 PAK5 | LsCNGGtPAGHKQMPWPEPQsPRVLPNGLAAKAQsLGPAEF |
| Q9NRR4 | S221 | PSP | DROSHA RN3 RNASE3L RNASEN | SPHFRHLPPYPLPKAPsERRsPERLKHYDDHRHRDHSHGRG |
| Q9NRR4 | S255 | PSP | DROSHA RN3 RNASE3L RNASEN | DHSHGRGERHRSLDRRERGRsPDRRRQDSRYRSDYDRGRtP |
| Q9NRR4 | S300 | SIGNOR|PSP | DROSHA RN3 RNASE3L RNASEN | SYERSRERERERHRHRDNRRsPsLERSYKKEYKRSGRSYGL |
| Q9NRR4 | S355 | PSP | DROSHA RN3 RNASE3L RNASEN | GEIIKNTDSWAPPLEIVNHRsPsREKKRARWEEEKDRWsDN |
| Q9NRR4 | T274 | PSP | DROSHA RN3 RNASE3L RNASEN | RsPDRRRQDSRYRSDYDRGRtPSRHRSYERSRERERERHRH |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NYB0 | S203 | Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NYU2 | S955 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | QLRVEEDVASDLVMKVDALLsAQPKGDPRIEyQFFEDRHSA |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9NZN8 | T246 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | DLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMVTKPA |
| Q9P2R3 | T455 | Sugiyama | ANKFY1 ANKHZN KIAA1255 | DENSFAARLIQRGSHTDAPDtATGNCLLQRAAGAGNEAAAL |
| Q9P2R7 | S79 | PSP | SUCLA2 | MSMELLQEAGVSVPKGYVAKsPDEAyAIAKKLGSKDVVIKA |
| Q9UBK2 | S266 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | SQSQHLQAKPTTLSLPLtPEsPNDPKGsPFENKTIERTLSV |
| Q9UBK2 | T263 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | HTQSQSQHLQAKPTTLSLPLtPEsPNDPKGsPFENKTIERT |
| Q9UBK2 | T299 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | TIERTLSVELSGTAGLTPPTtPPHKANQDNPFRAsPKLKSS |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHL4 | S213 | Sugiyama | DPP7 DPP2 QPP | AGLGDSNQFFRDVTADFEGQsPKCTQGVREAFRQIKDLFLQ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI30 | S125 | Sugiyama | TRMT112 AD-001 HSPC152 HSPC170 | RMFPISRGIPNMLLsEEEtEs____________________ |
| Q9UIG0 | S158 | SIGNOR|PSP | BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF | HPLEKVDEEATEKKsDGACDsPssDKENssQIAQDHQKKET |
| Q9UK80 | S538 | SIGNOR|PSP | USP21 USP23 PP1490 | HYTALCRCQTGWHVYNDSRVsPVSENQVASSEGYVLFYQLM |
| Q9UKV8 | S387 | PSP | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UKX7 | S221 | Sugiyama | NUP50 NPAP60L PRO1146 | HGNsGRNsESEsNKVAAEtQsPsLFGstKLQQEStFLFHGN |
| Q9ULD2 | S1264 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | RsPtssAIPLQsPRNsGsFPsPsIsPR______________ |
| Q9ULD2 | S1268 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ssAIPLQsPRNsGsFPsPsIsPR__________________ |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPQ0 | S217 | Sugiyama | LIMCH1 KIAA1102 | GRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEsDL |
| Q9UPQ0 | S299 | Sugiyama | LIMCH1 KIAA1102 | yVPAPLRKKKAEREEYRKsWstAtsPLGGERPFRYGPRtPV |
| Q9UPQ0 | S303 | Sugiyama | LIMCH1 KIAA1102 | PLRKKKAEREEYRKsWstAtsPLGGERPFRYGPRtPVSDDA |
| Q9UPQ0 | T215 | Sugiyama | LIMCH1 KIAA1102 | RHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEs |
| Q9UQ35 | S1320 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLG |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ80 | T382 | Sugiyama | PA2G4 EBP1 | AsRKtQKKKKKKAsKtAENAtsGEtLEENEAGD________ |
| Q9Y266 | T303 | Sugiyama | NUDC | tRsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMDQHPEM |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2L1 | S634 | Sugiyama | DIS3 KIAA1008 RRP44 | NKLAKILKKRRIEKGALTLssPEVRFHMDSETHDPIDLQTK |
| Q9Y2V2 | T45 | Sugiyama | CARHSP1 | RsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKG |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y3F4 | S228 | Sugiyama | STRAP MAWD UNRIP | FHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLy |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3X0 | S386 | Sugiyama | CCDC9 | DRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEIPAPAH |
| Q9Y3X0 | T381 | Sugiyama | CCDC9 | YsDHDDRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEI |
| Q9Y4E8 | S225 | Sugiyama | USP15 KIAA0529 | QGQVLVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPss |
| Q9Y4E8 | S229 | Sugiyama | USP15 KIAA0529 | LVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssLsNN |
| Q9Y676 | S42 | Sugiyama | MRPS18B C6orf14 HSPC183 PTD017 | SHRVQVPLQTLCTKAPsEEDsLSsVPIsPYKDEPWKYLESE |
| Q9Y676 | S49 | Sugiyama | MRPS18B C6orf14 HSPC183 PTD017 | LQTLCTKAPsEEDsLSsVPIsPYKDEPWKYLESEEYQERYG |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
| Q9Y6G9 | T515 | Sugiyama | DYNC1LI1 DNCLI1 | VHAELDRITRKPVtVsPttPtsPtEGEAs____________ |
| Q9Y6Q9 | S505 | SIGNOR|iPTMNet|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | RNRGSPKIASHQFSPVAGVHsPMAsSGNTGNHSFSSSSLSA |
| Q9Y6Q9 | S543 | SIGNOR|iPTMNet|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | LSALQAISEGVGTSLLSTLSsPGPKLDNsPNMNITQPSKVs |
| Q9Y6Q9 | S860 | SIGNOR|iPTMNet|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | KSSQSVQSIRPPYNRAVsLDsPVsVGssPPVKNISAFPMLP |
| Q9Y6Q9 | S867 | SIGNOR|iPTMNet|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | SIRPPYNRAVsLDsPVsVGssPPVKNISAFPMLPKQPMLGG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G1/S-Specific Transcription | R-HSA-69205 | 8.080259e-07 | 6.093 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.014864e-05 | 4.994 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.350471e-06 | 5.078 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.221902e-05 | 4.913 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.197117e-05 | 4.922 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.396113e-05 | 4.620 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.214243e-05 | 4.493 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.681598e-05 | 4.330 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.155615e-04 | 3.937 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.059045e-04 | 3.975 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.146853e-04 | 3.940 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.466272e-04 | 3.834 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.554173e-04 | 3.809 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.208984e-04 | 3.656 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.208984e-04 | 3.656 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.138886e-04 | 3.670 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.084693e-04 | 3.681 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.523988e-04 | 3.598 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.684292e-04 | 3.571 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.656006e-04 | 3.332 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.250126e-04 | 3.280 | 1 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.623630e-04 | 3.250 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.154026e-04 | 3.145 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.546867e-04 | 3.068 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.604283e-04 | 3.065 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.006672e-03 | 2.997 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.075534e-03 | 2.968 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.116623e-03 | 2.952 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.443773e-03 | 2.841 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.590990e-03 | 2.798 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.638135e-03 | 2.786 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.783300e-03 | 2.749 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.788426e-03 | 2.748 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.066544e-03 | 2.685 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.109766e-03 | 2.676 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.384021e-03 | 2.623 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.603572e-03 | 2.584 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.958029e-03 | 2.529 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.959765e-03 | 2.529 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.713921e-03 | 2.430 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.713921e-03 | 2.430 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.447603e-03 | 2.462 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.447603e-03 | 2.462 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.994376e-03 | 2.399 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.994376e-03 | 2.399 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.921222e-03 | 2.407 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.921222e-03 | 2.407 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.921222e-03 | 2.407 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.921222e-03 | 2.407 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.950212e-03 | 2.403 | 1 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.921222e-03 | 2.407 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.199005e-03 | 2.377 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.052735e-03 | 2.392 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.584430e-03 | 2.339 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.282254e-03 | 2.277 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.282254e-03 | 2.277 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.022726e-03 | 2.299 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.259436e-03 | 2.279 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.259436e-03 | 2.279 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.624611e-03 | 2.250 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.389196e-03 | 2.268 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.389196e-03 | 2.268 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.624611e-03 | 2.250 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.764432e-03 | 2.239 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.032264e-03 | 2.220 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.864505e-03 | 2.232 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.032264e-03 | 2.220 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.413737e-03 | 2.193 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.778934e-03 | 2.169 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.801686e-03 | 2.167 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.781300e-03 | 2.109 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.256186e-03 | 2.083 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.209979e-03 | 2.036 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.585879e-03 | 2.018 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.844519e-03 | 2.007 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.844519e-03 | 2.007 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.048837e-02 | 1.979 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.048837e-02 | 1.979 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.102309e-02 | 1.958 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.230073e-02 | 1.910 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.230073e-02 | 1.910 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.230073e-02 | 1.910 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.241948e-02 | 1.906 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.261640e-02 | 1.899 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.325843e-02 | 1.878 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.325843e-02 | 1.878 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.337735e-02 | 1.874 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.294273e-02 | 1.888 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.368173e-02 | 1.864 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.368173e-02 | 1.864 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.390763e-02 | 1.857 | 1 | 1 |
| Signal Transduction | R-HSA-162582 | 1.501940e-02 | 1.823 | 1 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.503578e-02 | 1.823 | 1 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.517033e-02 | 1.819 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.665235e-02 | 1.779 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.761700e-02 | 1.754 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.882382e-02 | 1.725 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.924058e-02 | 1.716 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.955405e-02 | 1.709 | 1 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.012983e-02 | 1.696 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.132895e-02 | 1.671 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.132895e-02 | 1.671 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.363900e-02 | 1.626 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.420211e-02 | 1.616 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.355847e-02 | 1.628 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.436678e-02 | 1.613 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.665018e-02 | 1.574 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.647639e-02 | 1.577 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.658267e-02 | 1.575 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.658267e-02 | 1.575 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.658267e-02 | 1.575 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.658267e-02 | 1.575 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.680474e-02 | 1.572 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.654710e-02 | 1.576 | 1 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.658267e-02 | 1.575 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.713168e-02 | 1.567 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.713168e-02 | 1.567 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.846638e-02 | 1.546 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.863772e-02 | 1.543 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.903379e-02 | 1.537 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.936923e-02 | 1.532 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.036406e-02 | 1.518 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.039285e-02 | 1.517 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.130406e-02 | 1.504 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.261375e-02 | 1.487 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.408434e-02 | 1.467 | 1 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.130406e-02 | 1.504 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.432008e-02 | 1.464 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.507634e-02 | 1.455 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.514163e-02 | 1.454 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.616068e-02 | 1.442 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.086441e-02 | 1.389 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.086441e-02 | 1.389 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.002003e-02 | 1.398 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.009338e-02 | 1.397 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.297854e-02 | 1.367 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.427584e-02 | 1.354 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.427584e-02 | 1.354 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.391267e-02 | 1.357 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.117460e-02 | 1.385 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.427584e-02 | 1.354 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.320000e-02 | 1.365 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.437934e-02 | 1.353 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.446743e-02 | 1.352 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.526402e-02 | 1.344 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.637545e-02 | 1.334 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.643255e-02 | 1.333 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.643255e-02 | 1.333 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.643255e-02 | 1.333 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.745389e-02 | 1.324 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.822409e-02 | 1.317 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.822409e-02 | 1.317 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.153561e-02 | 1.288 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.375246e-02 | 1.270 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.375246e-02 | 1.270 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.375246e-02 | 1.270 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.425920e-02 | 1.266 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.513950e-02 | 1.259 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.425920e-02 | 1.266 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.297449e-02 | 1.276 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.197482e-02 | 1.284 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.189352e-02 | 1.285 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.630859e-02 | 1.249 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.650176e-02 | 1.248 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.673842e-02 | 1.246 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.684432e-02 | 1.245 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.684432e-02 | 1.245 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.785963e-02 | 1.168 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.785963e-02 | 1.168 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.785963e-02 | 1.168 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.164956e-02 | 1.145 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 8.302635e-02 | 1.081 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.302635e-02 | 1.081 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 8.302635e-02 | 1.081 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.116626e-02 | 1.091 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.116626e-02 | 1.091 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.302635e-02 | 1.081 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.116626e-02 | 1.091 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.426280e-02 | 1.074 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.426280e-02 | 1.074 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.426280e-02 | 1.074 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.426280e-02 | 1.074 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.689075e-02 | 1.114 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.689075e-02 | 1.114 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.710567e-02 | 1.113 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.426280e-02 | 1.074 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.169001e-02 | 1.088 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.004183e-01 | 0.998 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.004183e-01 | 0.998 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 1.467844e-01 | 0.833 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.467844e-01 | 0.833 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 1.467844e-01 | 0.833 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.467844e-01 | 0.833 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 1.467844e-01 | 0.833 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 1.467844e-01 | 0.833 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.467844e-01 | 0.833 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.907633e-01 | 0.720 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.907633e-01 | 0.720 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.907633e-01 | 0.720 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 1.907633e-01 | 0.720 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.907633e-01 | 0.720 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.907633e-01 | 0.720 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 1.907633e-01 | 0.720 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.910624e-02 | 1.004 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 9.910624e-02 | 1.004 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 2.324779e-01 | 0.634 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.324779e-01 | 0.634 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 2.324779e-01 | 0.634 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.324779e-01 | 0.634 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 2.324779e-01 | 0.634 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.324779e-01 | 0.634 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.324779e-01 | 0.634 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.324779e-01 | 0.634 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.159651e-01 | 0.936 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.720446e-01 | 0.565 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.720446e-01 | 0.565 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.720446e-01 | 0.565 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.720446e-01 | 0.565 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.720446e-01 | 0.565 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.720446e-01 | 0.565 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.515395e-01 | 0.819 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 1.515395e-01 | 0.819 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.017107e-01 | 0.993 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.700402e-01 | 0.769 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.095739e-01 | 0.509 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.095739e-01 | 0.509 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.095739e-01 | 0.509 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.095739e-01 | 0.509 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.095739e-01 | 0.509 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.888893e-01 | 0.724 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.888893e-01 | 0.724 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.080018e-01 | 0.682 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.080018e-01 | 0.682 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.080018e-01 | 0.682 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.080018e-01 | 0.682 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.080018e-01 | 0.682 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.080018e-01 | 0.682 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.080018e-01 | 0.682 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.451705e-01 | 0.462 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.451705e-01 | 0.462 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.451705e-01 | 0.462 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.451705e-01 | 0.462 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.451705e-01 | 0.462 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.451705e-01 | 0.462 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.451705e-01 | 0.462 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.273005e-01 | 0.643 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.273005e-01 | 0.643 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.273005e-01 | 0.643 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.467157e-01 | 0.608 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.789339e-01 | 0.421 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.789339e-01 | 0.421 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.789339e-01 | 0.421 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.789339e-01 | 0.421 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.864019e-01 | 0.730 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.661841e-01 | 0.575 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.661841e-01 | 0.575 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.661841e-01 | 0.575 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.997229e-01 | 0.700 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.287796e-01 | 0.890 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.109583e-01 | 0.386 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.109583e-01 | 0.386 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.413333e-01 | 0.355 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.413333e-01 | 0.355 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.435338e-01 | 0.464 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.435338e-01 | 0.464 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.832506e-01 | 0.548 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.832506e-01 | 0.548 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.832506e-01 | 0.548 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.300032e-01 | 0.886 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.300032e-01 | 0.886 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.394333e-01 | 0.621 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.625217e-01 | 0.441 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.625217e-01 | 0.441 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.625217e-01 | 0.441 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.625217e-01 | 0.441 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.701437e-01 | 0.328 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.622454e-01 | 0.581 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.622454e-01 | 0.581 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.812985e-01 | 0.419 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.812985e-01 | 0.419 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.812985e-01 | 0.419 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.812985e-01 | 0.419 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.812985e-01 | 0.419 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.961239e-01 | 0.707 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.974700e-01 | 0.303 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.974700e-01 | 0.303 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.929852e-01 | 0.533 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.360924e-01 | 0.360 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.360924e-01 | 0.360 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.360924e-01 | 0.360 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.233886e-01 | 0.281 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.236205e-01 | 0.490 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.236205e-01 | 0.490 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.054620e-01 | 0.515 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.974464e-01 | 0.401 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.545811e-01 | 0.450 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.918859e-01 | 0.407 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.881497e-01 | 0.311 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.881497e-01 | 0.311 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.072943e-01 | 0.390 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.269282e-01 | 0.370 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.211404e-01 | 0.283 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.211404e-01 | 0.283 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.211404e-01 | 0.283 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.473759e-01 | 0.349 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.408760e-01 | 0.618 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.229122e-01 | 0.491 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.605268e-01 | 0.794 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.605268e-01 | 0.794 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.207619e-01 | 0.918 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.126817e-01 | 0.948 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.126817e-01 | 0.948 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.387922e-01 | 0.358 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 3.625217e-01 | 0.441 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.535248e-01 | 0.596 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.998354e-01 | 0.398 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.392924e-01 | 0.469 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.080018e-01 | 0.682 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.587656e-01 | 0.799 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.998354e-01 | 0.398 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.620067e-01 | 0.335 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.856488e-01 | 0.544 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.357957e-01 | 0.867 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.620067e-01 | 0.335 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.620067e-01 | 0.335 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.529643e-01 | 0.344 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.661841e-01 | 0.575 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.109583e-01 | 0.386 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.975301e-01 | 0.526 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.254388e-01 | 0.371 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.515395e-01 | 0.819 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.888893e-01 | 0.724 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.733268e-01 | 0.761 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.050585e-01 | 0.516 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.089246e-01 | 0.510 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.782460e-01 | 0.749 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 3.960049e-01 | 0.402 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.515395e-01 | 0.819 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.515395e-01 | 0.819 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.542953e-01 | 0.812 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.050585e-01 | 0.516 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.181074e-01 | 0.379 | 1 | 1 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.974464e-01 | 0.401 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.178137e-01 | 0.662 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.988975e-01 | 0.399 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.701437e-01 | 0.328 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.181074e-01 | 0.379 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.360924e-01 | 0.360 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.881497e-01 | 0.311 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.661841e-01 | 0.575 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.555263e-01 | 0.593 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.159651e-01 | 0.936 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.720446e-01 | 0.565 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.080018e-01 | 0.682 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.451705e-01 | 0.462 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.273005e-01 | 0.643 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.661841e-01 | 0.575 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.701437e-01 | 0.328 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.701437e-01 | 0.328 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.360924e-01 | 0.360 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.515459e-01 | 0.454 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.080018e-01 | 0.682 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.080018e-01 | 0.682 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.435338e-01 | 0.464 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.854448e-01 | 0.544 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.975301e-01 | 0.526 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.694855e-01 | 0.569 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.832506e-01 | 0.548 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.975301e-01 | 0.526 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.833089e-01 | 0.416 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.067644e-01 | 0.972 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.340228e-01 | 0.873 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.273005e-01 | 0.643 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.548275e-01 | 0.450 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.738035e-01 | 0.563 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.854498e-01 | 0.732 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 3.095739e-01 | 0.509 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.888893e-01 | 0.724 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.467157e-01 | 0.608 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 4.109583e-01 | 0.386 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.109583e-01 | 0.386 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.744360e-01 | 0.758 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.483261e-01 | 0.829 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.622454e-01 | 0.581 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.405171e-01 | 0.468 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.405171e-01 | 0.468 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.833089e-01 | 0.416 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.233886e-01 | 0.281 | 1 | 1 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.049684e-01 | 0.516 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 4.881497e-01 | 0.311 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.732741e-01 | 0.325 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.233886e-01 | 0.281 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.048235e-01 | 0.297 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.720446e-01 | 0.565 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.720446e-01 | 0.565 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.467157e-01 | 0.608 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.962206e-01 | 0.707 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.360924e-01 | 0.360 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.233886e-01 | 0.281 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.271486e-01 | 0.369 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.548275e-01 | 0.450 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.031473e-01 | 0.518 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.025435e-01 | 0.989 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.435338e-01 | 0.464 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.394333e-01 | 0.621 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.394333e-01 | 0.621 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.381944e-01 | 0.623 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.665218e-01 | 0.331 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.080018e-01 | 0.682 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.690972e-01 | 0.433 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.585338e-01 | 0.445 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.360924e-01 | 0.360 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.243397e-01 | 0.649 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.445097e-01 | 0.840 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.445097e-01 | 0.840 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.339152e-01 | 0.476 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.211404e-01 | 0.283 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.212242e-01 | 0.916 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 1.907633e-01 | 0.720 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.907633e-01 | 0.720 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.910624e-02 | 1.004 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.324779e-01 | 0.634 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.159651e-01 | 0.936 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.515395e-01 | 0.819 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.017107e-01 | 0.993 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.095739e-01 | 0.509 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.888893e-01 | 0.724 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 3.451705e-01 | 0.462 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.273005e-01 | 0.643 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.273005e-01 | 0.643 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.273005e-01 | 0.643 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.467157e-01 | 0.608 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.789339e-01 | 0.421 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.109583e-01 | 0.386 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.413333e-01 | 0.355 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.051742e-01 | 0.978 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.118485e-01 | 0.506 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.974700e-01 | 0.303 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.974700e-01 | 0.303 | 1 | 1 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.690972e-01 | 0.433 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.360924e-01 | 0.360 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.233886e-01 | 0.281 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.529643e-01 | 0.344 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.535253e-01 | 0.343 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.958141e-01 | 0.305 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.273159e-01 | 0.895 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.048235e-01 | 0.297 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.856488e-01 | 0.544 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.442381e-01 | 0.463 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.078841e-01 | 0.967 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.927427e-01 | 0.715 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.832704e-01 | 0.416 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.537716e-01 | 0.343 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.062498e-01 | 0.296 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.080018e-01 | 0.682 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.625217e-01 | 0.441 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.997229e-01 | 0.700 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.437092e-01 | 0.464 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.542953e-01 | 0.812 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.856488e-01 | 0.544 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.856488e-01 | 0.544 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.628979e-01 | 0.580 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.643465e-01 | 0.438 | 1 | 0 |
| Collagen degradation | R-HSA-1442490 | 1.625296e-01 | 0.789 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.776719e-01 | 0.750 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 2.720446e-01 | 0.565 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.661841e-01 | 0.575 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.661841e-01 | 0.575 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.243672e-01 | 0.489 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.812985e-01 | 0.419 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.690972e-01 | 0.433 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.070320e-01 | 0.513 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.997229e-01 | 0.700 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.812985e-01 | 0.419 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.622454e-01 | 0.581 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.334803e-01 | 0.875 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.080018e-01 | 0.682 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.080018e-01 | 0.682 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.080018e-01 | 0.682 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.451705e-01 | 0.462 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.467157e-01 | 0.608 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.109583e-01 | 0.386 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.551754e-01 | 0.809 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.625217e-01 | 0.441 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.974700e-01 | 0.303 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.254388e-01 | 0.371 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.711286e-01 | 0.327 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.380264e-01 | 0.623 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.530303e-01 | 0.597 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.371729e-01 | 0.359 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.207375e-01 | 0.494 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.413333e-01 | 0.355 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.908634e-01 | 0.408 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.130863e-01 | 0.671 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.848278e-01 | 0.733 | 1 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.881497e-01 | 0.311 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.666971e-01 | 0.574 | 1 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.975301e-01 | 0.526 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.480320e-01 | 0.830 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.282068e-01 | 0.642 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.938206e-01 | 0.532 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.191483e-01 | 0.285 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.974464e-01 | 0.401 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.022387e-02 | 1.045 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.191483e-01 | 0.285 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.866639e-01 | 0.413 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.324779e-01 | 0.634 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.515395e-01 | 0.819 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.451705e-01 | 0.462 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.999271e-02 | 1.000 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.109583e-01 | 0.386 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.548995e-01 | 0.594 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.284088e-02 | 1.032 | 1 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.625217e-01 | 0.441 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.701437e-01 | 0.328 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 3.812985e-01 | 0.419 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.974700e-01 | 0.303 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.072603e-01 | 0.970 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.233886e-01 | 0.281 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.751708e-01 | 0.426 | 1 | 1 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.782460e-01 | 0.749 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.833089e-01 | 0.416 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.468788e-01 | 0.350 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.116406e-01 | 0.952 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.269876e-01 | 0.644 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.444480e-01 | 0.463 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.665218e-01 | 0.331 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.226376e-01 | 0.374 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.620067e-01 | 0.335 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 3.120640e-01 | 0.506 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.998354e-01 | 0.398 | 1 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.811348e-01 | 0.551 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.519077e-01 | 0.599 | 1 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.999271e-02 | 1.000 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.364243e-01 | 0.626 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.854448e-01 | 0.544 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.947674e-01 | 0.710 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.833089e-01 | 0.416 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.614097e-01 | 0.583 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 5.048235e-01 | 0.297 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.328925e-01 | 0.364 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.042042e-01 | 0.982 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.191483e-01 | 0.285 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.762736e-01 | 0.424 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.408760e-01 | 0.618 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.243672e-01 | 0.489 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.089246e-01 | 0.510 | 1 | 1 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.542953e-01 | 0.812 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.960049e-01 | 0.402 | 1 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.526067e-01 | 0.598 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.720446e-01 | 0.565 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.095739e-01 | 0.509 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 1.888893e-01 | 0.724 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 3.451705e-01 | 0.462 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.467157e-01 | 0.608 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.789339e-01 | 0.421 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.856488e-01 | 0.544 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.109583e-01 | 0.386 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 3.050585e-01 | 0.516 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.413333e-01 | 0.355 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.238109e-01 | 0.907 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.701437e-01 | 0.328 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.701437e-01 | 0.328 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.701437e-01 | 0.328 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.701437e-01 | 0.328 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.118485e-01 | 0.506 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.405171e-01 | 0.468 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.974700e-01 | 0.303 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.974700e-01 | 0.303 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 4.974700e-01 | 0.303 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.233886e-01 | 0.281 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 5.048235e-01 | 0.297 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.958141e-01 | 0.305 | 1 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.975678e-01 | 0.303 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.432426e-01 | 0.614 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.072943e-01 | 0.390 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.119595e-02 | 1.040 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.998354e-01 | 0.398 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.473401e-01 | 0.832 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.269876e-01 | 0.644 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.408760e-01 | 0.618 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.475664e-02 | 1.023 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.490921e-01 | 0.604 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.360924e-01 | 0.360 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.080018e-01 | 0.682 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 3.050585e-01 | 0.516 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.960049e-01 | 0.402 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.864019e-01 | 0.730 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.435338e-01 | 0.464 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.405171e-01 | 0.468 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.181074e-01 | 0.379 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.502031e-01 | 0.347 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.207375e-01 | 0.494 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.095739e-01 | 0.509 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.451705e-01 | 0.462 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.451705e-01 | 0.462 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.451705e-01 | 0.462 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.451705e-01 | 0.462 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.789339e-01 | 0.421 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.357957e-01 | 0.867 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.701437e-01 | 0.328 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.701437e-01 | 0.328 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.428746e-01 | 0.615 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.048235e-01 | 0.297 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.420624e-01 | 0.848 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.648522e-01 | 0.783 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.366239e-01 | 0.473 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.676334e-01 | 0.330 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.747486e-01 | 0.561 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 2.061835e-01 | 0.686 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.346679e-01 | 0.630 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.445097e-01 | 0.840 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.441516e-01 | 0.463 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.728520e-01 | 0.564 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.700011e-01 | 0.770 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.270622e-01 | 0.896 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.997229e-01 | 0.700 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.109583e-01 | 0.386 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.701437e-01 | 0.328 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.681934e-01 | 0.434 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.105698e-01 | 0.508 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.881497e-01 | 0.311 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.931738e-01 | 0.307 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.069296e-01 | 0.295 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.357957e-01 | 0.867 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.931738e-01 | 0.307 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.269876e-01 | 0.644 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 4.711286e-01 | 0.327 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.876567e-01 | 0.312 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.243672e-01 | 0.489 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.526067e-01 | 0.598 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.095739e-01 | 0.509 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.413333e-01 | 0.355 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.701437e-01 | 0.328 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.233886e-01 | 0.281 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.937495e-01 | 0.306 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.610185e-01 | 0.793 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.652904e-01 | 0.437 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.095739e-01 | 0.509 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.109583e-01 | 0.386 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.273159e-01 | 0.895 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.181074e-01 | 0.379 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.269282e-01 | 0.370 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.243672e-01 | 0.489 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.025349e-01 | 0.519 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.413333e-01 | 0.355 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.701437e-01 | 0.328 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.477457e-01 | 0.459 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.054017e-01 | 0.515 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.732269e-01 | 0.428 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.211404e-01 | 0.283 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.547888e-01 | 0.810 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.413386e-01 | 0.355 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 5.236985e-01 | 0.281 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.268430e-01 | 0.278 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.318620e-01 | 0.274 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.318620e-01 | 0.274 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.318620e-01 | 0.274 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.325298e-01 | 0.274 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.364346e-01 | 0.270 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.370929e-01 | 0.270 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.370929e-01 | 0.270 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.370929e-01 | 0.270 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.370929e-01 | 0.270 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.370929e-01 | 0.270 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.370929e-01 | 0.270 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.405499e-01 | 0.267 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.459363e-01 | 0.263 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.479718e-01 | 0.261 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.479718e-01 | 0.261 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.479718e-01 | 0.261 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.479718e-01 | 0.261 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.479718e-01 | 0.261 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.479718e-01 | 0.261 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.479718e-01 | 0.261 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.479718e-01 | 0.261 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.513232e-01 | 0.259 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.514587e-01 | 0.258 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.526752e-01 | 0.258 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.526752e-01 | 0.258 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.526752e-01 | 0.258 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.526752e-01 | 0.258 | 1 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.553444e-01 | 0.255 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.567099e-01 | 0.254 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.607387e-01 | 0.251 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.646556e-01 | 0.248 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.678831e-01 | 0.246 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.678831e-01 | 0.246 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.684239e-01 | 0.245 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.711134e-01 | 0.243 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.712885e-01 | 0.243 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.712885e-01 | 0.243 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.712885e-01 | 0.243 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.712885e-01 | 0.243 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.712885e-01 | 0.243 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.712885e-01 | 0.243 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.712885e-01 | 0.243 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.813497e-01 | 0.236 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.827022e-01 | 0.235 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.827137e-01 | 0.235 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.827137e-01 | 0.235 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.827137e-01 | 0.235 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.827137e-01 | 0.235 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.873992e-01 | 0.231 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.924559e-01 | 0.227 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.934038e-01 | 0.227 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.934038e-01 | 0.227 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.934038e-01 | 0.227 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.934038e-01 | 0.227 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.934038e-01 | 0.227 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.934038e-01 | 0.227 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.934038e-01 | 0.227 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.934038e-01 | 0.227 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.934038e-01 | 0.227 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.939800e-01 | 0.226 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.971655e-01 | 0.224 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.971655e-01 | 0.224 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.971655e-01 | 0.224 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.971655e-01 | 0.224 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.971655e-01 | 0.224 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.997614e-01 | 0.222 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.011242e-01 | 0.221 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.013938e-01 | 0.221 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.039484e-01 | 0.219 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.055051e-01 | 0.218 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.112381e-01 | 0.214 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.112381e-01 | 0.214 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.112381e-01 | 0.214 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.112381e-01 | 0.214 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.112381e-01 | 0.214 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.112381e-01 | 0.214 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.120734e-01 | 0.213 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.143796e-01 | 0.212 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.143796e-01 | 0.212 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.143796e-01 | 0.212 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.143796e-01 | 0.212 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.143796e-01 | 0.212 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.143796e-01 | 0.212 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.143796e-01 | 0.212 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.143796e-01 | 0.212 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.143796e-01 | 0.212 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.152243e-01 | 0.211 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.152243e-01 | 0.211 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.152243e-01 | 0.211 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.177668e-01 | 0.209 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.249321e-01 | 0.204 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.249321e-01 | 0.204 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.250789e-01 | 0.204 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.262815e-01 | 0.203 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 6.303477e-01 | 0.200 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.342744e-01 | 0.198 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.342744e-01 | 0.198 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.342744e-01 | 0.198 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.342744e-01 | 0.198 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 6.342744e-01 | 0.198 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.342744e-01 | 0.198 | 1 | 1 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.342744e-01 | 0.198 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.342744e-01 | 0.198 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.342744e-01 | 0.198 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.371184e-01 | 0.196 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.382492e-01 | 0.195 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.382492e-01 | 0.195 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.382492e-01 | 0.195 | 1 | 1 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.382492e-01 | 0.195 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.396936e-01 | 0.194 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.428221e-01 | 0.192 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.477336e-01 | 0.189 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.511918e-01 | 0.186 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.531440e-01 | 0.185 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.531440e-01 | 0.185 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.531440e-01 | 0.185 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.531440e-01 | 0.185 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.531440e-01 | 0.185 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.531440e-01 | 0.185 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.531440e-01 | 0.185 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.531440e-01 | 0.185 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.531440e-01 | 0.185 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.581263e-01 | 0.182 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.581263e-01 | 0.182 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.637631e-01 | 0.178 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.637631e-01 | 0.178 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.641064e-01 | 0.178 | 1 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.672021e-01 | 0.176 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.679023e-01 | 0.175 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.710411e-01 | 0.173 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.710411e-01 | 0.173 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.710411e-01 | 0.173 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.710411e-01 | 0.173 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.710411e-01 | 0.173 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.710411e-01 | 0.173 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.710411e-01 | 0.173 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.759668e-01 | 0.170 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 6.759668e-01 | 0.170 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.759668e-01 | 0.170 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.785098e-01 | 0.168 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.825745e-01 | 0.166 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.840663e-01 | 0.165 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.840663e-01 | 0.165 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.878076e-01 | 0.163 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 6.878076e-01 | 0.163 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.878076e-01 | 0.163 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.878076e-01 | 0.163 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.878621e-01 | 0.162 | 1 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.879672e-01 | 0.162 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.880157e-01 | 0.162 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.880157e-01 | 0.162 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.880157e-01 | 0.162 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.880157e-01 | 0.162 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.880157e-01 | 0.162 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 6.880157e-01 | 0.162 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.880157e-01 | 0.162 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.880157e-01 | 0.162 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.974695e-01 | 0.156 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.979365e-01 | 0.156 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.992902e-01 | 0.155 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.992996e-01 | 0.155 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.004274e-01 | 0.155 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.010361e-01 | 0.154 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.041155e-01 | 0.152 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.041155e-01 | 0.152 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.041155e-01 | 0.152 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.041155e-01 | 0.152 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.041155e-01 | 0.152 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.041155e-01 | 0.152 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.041155e-01 | 0.152 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.041155e-01 | 0.152 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.041155e-01 | 0.152 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.041155e-01 | 0.152 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.050535e-01 | 0.152 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.067507e-01 | 0.151 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.069293e-01 | 0.151 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.072998e-01 | 0.150 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.104202e-01 | 0.148 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.104202e-01 | 0.148 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.104202e-01 | 0.148 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.104202e-01 | 0.148 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.130298e-01 | 0.147 | 1 | 1 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.158122e-01 | 0.145 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.158122e-01 | 0.145 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.158122e-01 | 0.145 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.193853e-01 | 0.143 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.193853e-01 | 0.143 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.193853e-01 | 0.143 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.193853e-01 | 0.143 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.193853e-01 | 0.143 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.212034e-01 | 0.142 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.212034e-01 | 0.142 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.244527e-01 | 0.140 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.246555e-01 | 0.140 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.316458e-01 | 0.136 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.316458e-01 | 0.136 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.316458e-01 | 0.136 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 7.316458e-01 | 0.136 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.316458e-01 | 0.136 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.338680e-01 | 0.134 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.338680e-01 | 0.134 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.338680e-01 | 0.134 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.338680e-01 | 0.134 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.338680e-01 | 0.134 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.338680e-01 | 0.134 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.339122e-01 | 0.134 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.339122e-01 | 0.134 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.352484e-01 | 0.134 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.435670e-01 | 0.129 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.476040e-01 | 0.126 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.476040e-01 | 0.126 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.476040e-01 | 0.126 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.476040e-01 | 0.126 | 1 | 1 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.476040e-01 | 0.126 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.476040e-01 | 0.126 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.515345e-01 | 0.124 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.536677e-01 | 0.123 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.539012e-01 | 0.123 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.578844e-01 | 0.120 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.606319e-01 | 0.119 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.606319e-01 | 0.119 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.606319e-01 | 0.119 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.606319e-01 | 0.119 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.606319e-01 | 0.119 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.606319e-01 | 0.119 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.606319e-01 | 0.119 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.609943e-01 | 0.119 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.616392e-01 | 0.118 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.645436e-01 | 0.117 | 1 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.662174e-01 | 0.116 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.696873e-01 | 0.114 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.701404e-01 | 0.113 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.729880e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.729880e-01 | 0.112 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.729880e-01 | 0.112 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.729880e-01 | 0.112 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.729880e-01 | 0.112 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.789800e-01 | 0.108 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.789800e-01 | 0.108 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.806208e-01 | 0.108 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.841243e-01 | 0.106 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.841243e-01 | 0.106 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.847071e-01 | 0.105 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.847071e-01 | 0.105 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.847071e-01 | 0.105 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.847071e-01 | 0.105 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.847071e-01 | 0.105 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.847071e-01 | 0.105 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.847071e-01 | 0.105 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.847071e-01 | 0.105 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.847071e-01 | 0.105 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.872279e-01 | 0.104 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.875203e-01 | 0.104 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.875203e-01 | 0.104 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.877979e-01 | 0.104 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.877979e-01 | 0.104 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.940213e-01 | 0.100 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.953523e-01 | 0.099 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.953523e-01 | 0.099 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.958218e-01 | 0.099 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.958218e-01 | 0.099 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.958218e-01 | 0.099 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.958218e-01 | 0.099 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.958218e-01 | 0.099 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.958218e-01 | 0.099 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.958218e-01 | 0.099 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.958218e-01 | 0.099 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.995097e-01 | 0.097 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.015677e-01 | 0.096 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.015677e-01 | 0.096 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.037324e-01 | 0.095 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.037324e-01 | 0.095 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.054326e-01 | 0.094 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.063245e-01 | 0.093 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.063634e-01 | 0.093 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.063634e-01 | 0.093 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.063634e-01 | 0.093 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.063634e-01 | 0.093 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 8.063634e-01 | 0.093 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.083022e-01 | 0.092 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.114190e-01 | 0.091 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.163613e-01 | 0.088 | 1 | 1 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.163613e-01 | 0.088 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.163613e-01 | 0.088 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.163613e-01 | 0.088 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.163613e-01 | 0.088 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.208104e-01 | 0.086 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.216718e-01 | 0.085 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.258436e-01 | 0.083 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.258436e-01 | 0.083 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 8.258436e-01 | 0.083 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.258436e-01 | 0.083 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.258436e-01 | 0.083 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.258436e-01 | 0.083 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.258436e-01 | 0.083 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.259901e-01 | 0.083 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.277136e-01 | 0.082 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.277136e-01 | 0.082 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.277136e-01 | 0.082 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.277136e-01 | 0.082 | 1 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.327371e-01 | 0.079 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.328892e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.328892e-01 | 0.079 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.348368e-01 | 0.078 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.348368e-01 | 0.078 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.404767e-01 | 0.075 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.407715e-01 | 0.075 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.408553e-01 | 0.075 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.430000e-01 | 0.074 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.433661e-01 | 0.074 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.433661e-01 | 0.074 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.433661e-01 | 0.074 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.433661e-01 | 0.074 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.433661e-01 | 0.074 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.433661e-01 | 0.074 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.439749e-01 | 0.074 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.514555e-01 | 0.070 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.514555e-01 | 0.070 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.521281e-01 | 0.069 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.545523e-01 | 0.068 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.591275e-01 | 0.066 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.591275e-01 | 0.066 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.591275e-01 | 0.066 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.644980e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.659357e-01 | 0.063 | 1 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.664037e-01 | 0.062 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.664037e-01 | 0.062 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.682153e-01 | 0.061 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.693272e-01 | 0.061 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.693272e-01 | 0.061 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.693272e-01 | 0.061 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.701616e-01 | 0.060 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.701616e-01 | 0.060 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.733046e-01 | 0.059 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.733046e-01 | 0.059 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.733046e-01 | 0.059 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.733046e-01 | 0.059 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.733046e-01 | 0.059 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.733046e-01 | 0.059 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.746390e-01 | 0.058 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.746390e-01 | 0.058 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.750431e-01 | 0.058 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.782702e-01 | 0.056 | 1 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.782702e-01 | 0.056 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 8.797511e-01 | 0.056 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.798493e-01 | 0.056 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.798493e-01 | 0.056 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.798493e-01 | 0.056 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.798493e-01 | 0.056 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.821575e-01 | 0.054 | 1 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.823889e-01 | 0.054 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.846701e-01 | 0.053 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.859364e-01 | 0.053 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.859364e-01 | 0.053 | 1 | 0 |
| eNOS activation | R-HSA-203615 | 8.860564e-01 | 0.053 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.860564e-01 | 0.053 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.860564e-01 | 0.053 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.860564e-01 | 0.053 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.860564e-01 | 0.053 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.860564e-01 | 0.053 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.867851e-01 | 0.052 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.894022e-01 | 0.051 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.894022e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.919431e-01 | 0.050 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.919431e-01 | 0.050 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.919431e-01 | 0.050 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.939537e-01 | 0.049 | 1 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.966458e-01 | 0.047 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.975261e-01 | 0.047 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.975261e-01 | 0.047 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.975261e-01 | 0.047 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.983304e-01 | 0.047 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.985302e-01 | 0.046 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.000139e-01 | 0.046 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.021945e-01 | 0.045 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.025384e-01 | 0.045 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.028209e-01 | 0.044 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.028209e-01 | 0.044 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.047891e-01 | 0.043 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.049793e-01 | 0.043 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.053860e-01 | 0.043 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.057390e-01 | 0.043 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.064609e-01 | 0.043 | 1 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.078425e-01 | 0.042 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.078425e-01 | 0.042 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.091668e-01 | 0.041 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.095716e-01 | 0.041 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.104708e-01 | 0.041 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.104708e-01 | 0.041 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.126048e-01 | 0.040 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.126048e-01 | 0.040 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.126048e-01 | 0.040 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.126048e-01 | 0.040 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.126048e-01 | 0.040 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.156855e-01 | 0.038 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.171213e-01 | 0.038 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.171213e-01 | 0.038 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.171213e-01 | 0.038 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.171213e-01 | 0.038 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.176648e-01 | 0.037 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.176648e-01 | 0.037 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.176648e-01 | 0.037 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.177953e-01 | 0.037 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.177953e-01 | 0.037 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.187825e-01 | 0.037 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.187825e-01 | 0.037 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.202113e-01 | 0.036 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.209921e-01 | 0.036 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.209921e-01 | 0.036 | 1 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.212427e-01 | 0.036 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.212427e-01 | 0.036 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.212427e-01 | 0.036 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.212427e-01 | 0.036 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.214047e-01 | 0.036 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.214047e-01 | 0.036 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.214047e-01 | 0.036 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.214047e-01 | 0.036 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.214047e-01 | 0.036 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.217753e-01 | 0.035 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.217753e-01 | 0.035 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.233182e-01 | 0.035 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.245536e-01 | 0.034 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.250728e-01 | 0.034 | 1 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.254670e-01 | 0.034 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.254670e-01 | 0.034 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.254670e-01 | 0.034 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.254670e-01 | 0.034 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.287073e-01 | 0.032 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.287073e-01 | 0.032 | 1 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.293195e-01 | 0.032 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.293195e-01 | 0.032 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.293195e-01 | 0.032 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.307856e-01 | 0.031 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.311240e-01 | 0.031 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.329731e-01 | 0.030 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.329731e-01 | 0.030 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.337159e-01 | 0.030 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.340203e-01 | 0.030 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.352800e-01 | 0.029 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.364381e-01 | 0.029 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.364381e-01 | 0.029 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.364381e-01 | 0.029 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.364381e-01 | 0.029 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.365285e-01 | 0.028 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.381950e-01 | 0.028 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 9.388769e-01 | 0.027 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.391416e-01 | 0.027 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.397241e-01 | 0.027 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.397241e-01 | 0.027 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.397241e-01 | 0.027 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.397241e-01 | 0.027 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.400529e-01 | 0.027 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.415671e-01 | 0.026 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.418177e-01 | 0.026 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.418177e-01 | 0.026 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.423152e-01 | 0.026 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.423152e-01 | 0.026 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.428404e-01 | 0.026 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.428404e-01 | 0.026 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.436943e-01 | 0.025 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.444982e-01 | 0.025 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.457958e-01 | 0.024 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.466862e-01 | 0.024 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.474985e-01 | 0.023 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.484207e-01 | 0.023 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.485986e-01 | 0.023 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.485986e-01 | 0.023 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.497550e-01 | 0.022 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.500801e-01 | 0.022 | 1 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.503986e-01 | 0.022 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.504030e-01 | 0.022 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.505953e-01 | 0.022 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.512566e-01 | 0.022 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.512566e-01 | 0.022 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.515113e-01 | 0.022 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.524848e-01 | 0.021 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.524848e-01 | 0.021 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.532676e-01 | 0.021 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.537773e-01 | 0.021 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.537773e-01 | 0.021 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.541672e-01 | 0.020 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.543067e-01 | 0.020 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.552834e-01 | 0.020 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.561678e-01 | 0.019 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.561678e-01 | 0.019 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.561678e-01 | 0.019 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.561678e-01 | 0.019 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.576502e-01 | 0.019 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.584348e-01 | 0.018 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.584348e-01 | 0.018 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.593881e-01 | 0.018 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.605847e-01 | 0.017 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.605847e-01 | 0.017 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.605847e-01 | 0.017 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.605847e-01 | 0.017 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.622745e-01 | 0.017 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.623083e-01 | 0.017 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.625450e-01 | 0.017 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.625450e-01 | 0.017 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.626235e-01 | 0.017 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.626235e-01 | 0.017 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.626235e-01 | 0.017 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.636548e-01 | 0.016 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.645570e-01 | 0.016 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.645570e-01 | 0.016 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.649204e-01 | 0.016 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.663906e-01 | 0.015 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.663906e-01 | 0.015 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.672336e-01 | 0.014 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.680007e-01 | 0.014 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.680007e-01 | 0.014 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.681294e-01 | 0.014 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.697783e-01 | 0.013 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.697783e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.713421e-01 | 0.013 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.713421e-01 | 0.013 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.713548e-01 | 0.013 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.713548e-01 | 0.013 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.713548e-01 | 0.013 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.714780e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.726139e-01 | 0.012 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.728250e-01 | 0.012 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.728250e-01 | 0.012 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.759769e-01 | 0.011 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.760738e-01 | 0.011 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.760787e-01 | 0.011 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.768294e-01 | 0.010 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.771365e-01 | 0.010 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.771365e-01 | 0.010 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.775370e-01 | 0.010 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.780287e-01 | 0.010 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.780287e-01 | 0.010 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.781489e-01 | 0.010 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.791179e-01 | 0.009 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.791660e-01 | 0.009 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.791669e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.791669e-01 | 0.009 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.794534e-01 | 0.009 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.803200e-01 | 0.009 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.806403e-01 | 0.008 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.809325e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.812671e-01 | 0.008 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.812671e-01 | 0.008 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.812671e-01 | 0.008 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.817815e-01 | 0.008 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.848557e-01 | 0.007 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.848557e-01 | 0.007 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.848557e-01 | 0.007 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.852568e-01 | 0.006 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.852910e-01 | 0.006 | 1 | 0 |
| Ion channel transport | R-HSA-983712 | 9.854047e-01 | 0.006 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.855053e-01 | 0.006 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.856399e-01 | 0.006 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.863835e-01 | 0.006 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.864245e-01 | 0.006 | 1 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.873722e-01 | 0.006 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.877574e-01 | 0.005 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.877574e-01 | 0.005 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.883915e-01 | 0.005 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.885222e-01 | 0.005 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.885222e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.889928e-01 | 0.005 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.893918e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.895630e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.895630e-01 | 0.005 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.904029e-01 | 0.004 | 1 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.908636e-01 | 0.004 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.910866e-01 | 0.004 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.911026e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.915719e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.916744e-01 | 0.004 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.924153e-01 | 0.003 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.925958e-01 | 0.003 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.928084e-01 | 0.003 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.931811e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.935345e-01 | 0.003 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.936588e-01 | 0.003 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.937073e-01 | 0.003 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.939247e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.941798e-01 | 0.003 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.947745e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.947745e-01 | 0.002 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.949480e-01 | 0.002 | 1 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.959958e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.960453e-01 | 0.002 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.960453e-01 | 0.002 | 1 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.963824e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.965871e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.969320e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.969320e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.970098e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.970912e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.972421e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.973083e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.973403e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.974232e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.974502e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.976495e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.976665e-01 | 0.001 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.977715e-01 | 0.001 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.984655e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.984655e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.985451e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.986859e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.987946e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.988064e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.989435e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.990504e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.991062e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.991484e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.992329e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.993307e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.993464e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.993886e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.993890e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.994220e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.995771e-01 | 0.000 | 1 | 1 |
| Sensory perception of taste | R-HSA-9717189 | 9.995957e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.997007e-01 | 0.000 | 1 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.997490e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.997598e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998222e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998333e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999058e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999449e-01 | 0.000 | 1 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999574e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.999594e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999599e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999636e-01 | 0.000 | 1 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999636e-01 | 0.000 | 1 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999721e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999766e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999818e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999821e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999826e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999843e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999875e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999875e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999907e-01 | 0.000 | 1 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999924e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999941e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999960e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999972e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999973e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999975e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999990e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999997e-01 | 0.000 | 1 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.000000e+00 | 0.000 | 1 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.000000e+00 | 0.000 | 1 | 1 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.000000e+00 | 0.000 | 1 | 1 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 2.498002e-14 | 13.602 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.050715e-14 | 13.218 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.237643e-11 | 10.907 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.306466e-11 | 10.275 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.310006e-09 | 8.636 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.469040e-08 | 7.607 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.745192e-08 | 7.427 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.435991e-08 | 7.353 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.302245e-07 | 6.638 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.759018e-07 | 6.559 | 1 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.093062e-07 | 6.215 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.764246e-06 | 5.322 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.842074e-06 | 5.233 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.093098e-06 | 5.215 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.752581e-06 | 5.171 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.694935e-05 | 4.771 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.694935e-05 | 4.771 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.861405e-05 | 4.730 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.326502e-05 | 4.633 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.540215e-05 | 4.595 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.067397e-05 | 4.513 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.445164e-05 | 4.352 | 1 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.724412e-05 | 4.242 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.274729e-05 | 4.202 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.959923e-05 | 4.157 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.213788e-05 | 4.142 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.506598e-05 | 4.125 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.045840e-04 | 3.981 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.225028e-04 | 3.912 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.409576e-04 | 3.851 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.563285e-04 | 3.806 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.551418e-04 | 3.809 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.683103e-04 | 3.774 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.773352e-04 | 3.751 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.198932e-04 | 3.658 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.190113e-04 | 3.660 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.206992e-04 | 3.656 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.382879e-04 | 3.623 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.534535e-04 | 3.596 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.472497e-04 | 3.607 | 1 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.806760e-04 | 3.552 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.806760e-04 | 3.552 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.200114e-04 | 3.495 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.268892e-04 | 3.486 | 1 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.551551e-04 | 3.450 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.708416e-04 | 3.431 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.667320e-04 | 3.436 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.722019e-04 | 3.429 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.234894e-04 | 3.373 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.457056e-04 | 3.351 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.457056e-04 | 3.351 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.206722e-04 | 3.376 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.676747e-04 | 3.330 | 1 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.726696e-04 | 3.325 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.722217e-04 | 3.326 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.933321e-04 | 3.307 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.026070e-04 | 3.299 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.174644e-04 | 3.286 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.471021e-04 | 3.262 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.772115e-04 | 3.239 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.549816e-04 | 3.256 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.780174e-04 | 3.238 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.780174e-04 | 3.238 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 7.012629e-04 | 3.154 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.012629e-04 | 3.154 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.012629e-04 | 3.154 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.859293e-04 | 3.164 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.504227e-04 | 3.125 | 1 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.011087e-04 | 3.096 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.417975e-04 | 3.075 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.915195e-04 | 3.050 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.983592e-04 | 3.047 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.037043e-04 | 3.044 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.800702e-04 | 3.009 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.958056e-04 | 3.002 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.098230e-03 | 2.959 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.098230e-03 | 2.959 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.215495e-03 | 2.915 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.220070e-03 | 2.914 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.228004e-03 | 2.911 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.242860e-03 | 2.906 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.242860e-03 | 2.906 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.260724e-03 | 2.899 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.347228e-03 | 2.871 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.356871e-03 | 2.867 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.356871e-03 | 2.867 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.356871e-03 | 2.867 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.374193e-03 | 2.862 | 1 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.383896e-03 | 2.859 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.533845e-03 | 2.814 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.710106e-03 | 2.767 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.820553e-03 | 2.740 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.791497e-03 | 2.747 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.790513e-03 | 2.747 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.790513e-03 | 2.747 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.820553e-03 | 2.740 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.857705e-03 | 2.731 | 1 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.790513e-03 | 2.747 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.043220e-03 | 2.690 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.043220e-03 | 2.690 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.056307e-03 | 2.687 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.068044e-03 | 2.684 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.130837e-03 | 2.671 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.203428e-03 | 2.657 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.221854e-03 | 2.653 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.344294e-03 | 2.630 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.330177e-03 | 2.633 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.356969e-03 | 2.628 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.403285e-03 | 2.619 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.418702e-03 | 2.616 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.643364e-03 | 2.578 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.517778e-03 | 2.599 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.522286e-03 | 2.598 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.517778e-03 | 2.599 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.522286e-03 | 2.598 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.742098e-03 | 2.562 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.742098e-03 | 2.562 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.742098e-03 | 2.562 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.989712e-03 | 2.524 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.005812e-03 | 2.522 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.014321e-03 | 2.521 | 1 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.102235e-03 | 2.508 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.194436e-03 | 2.496 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.328236e-03 | 2.478 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.233169e-03 | 2.490 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.512668e-03 | 2.454 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.732672e-03 | 2.428 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.808448e-03 | 2.419 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.912587e-03 | 2.408 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.100345e-03 | 2.387 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.287714e-03 | 2.368 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.671152e-03 | 2.331 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.718592e-03 | 2.326 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.937860e-03 | 2.306 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.563268e-03 | 2.255 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.500849e-03 | 2.260 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.448881e-03 | 2.264 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.861999e-03 | 2.232 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.575976e-03 | 2.254 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.009331e-03 | 2.221 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.018172e-03 | 2.221 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.128760e-03 | 2.213 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.132069e-03 | 2.212 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.137872e-03 | 2.212 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.272495e-03 | 2.203 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.272495e-03 | 2.203 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.272495e-03 | 2.203 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.272495e-03 | 2.203 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.272495e-03 | 2.203 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 6.791510e-03 | 2.168 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.154692e-03 | 2.145 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.987595e-03 | 2.098 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.051910e-03 | 2.094 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.213162e-03 | 2.085 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.060485e-03 | 2.094 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.255052e-03 | 2.083 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.800769e-03 | 2.055 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.037237e-03 | 2.044 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.037237e-03 | 2.044 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.037237e-03 | 2.044 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.037237e-03 | 2.044 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.139269e-03 | 2.039 | 1 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.254282e-03 | 2.034 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.345374e-03 | 2.029 | 1 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.022068e-02 | 1.991 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.066148e-02 | 1.972 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.038493e-02 | 1.984 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.038493e-02 | 1.984 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.066148e-02 | 1.972 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.032758e-02 | 1.986 | 1 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.078219e-02 | 1.967 | 1 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.022068e-02 | 1.991 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.167888e-02 | 1.933 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.237770e-02 | 1.907 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.253520e-02 | 1.902 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.281196e-02 | 1.892 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.282615e-02 | 1.892 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.296249e-02 | 1.887 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.306216e-02 | 1.884 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.306216e-02 | 1.884 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.320117e-02 | 1.879 | 1 | 1 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.458643e-02 | 1.836 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.458643e-02 | 1.836 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.514564e-02 | 1.820 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.529516e-02 | 1.815 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.560002e-02 | 1.807 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.577376e-02 | 1.802 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.577376e-02 | 1.802 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.577376e-02 | 1.802 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.595362e-02 | 1.797 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.599921e-02 | 1.796 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.620342e-02 | 1.790 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.859754e-02 | 1.731 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.722429e-02 | 1.764 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.836675e-02 | 1.736 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.836675e-02 | 1.736 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.809270e-02 | 1.742 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.885880e-02 | 1.724 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.909975e-02 | 1.719 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.909975e-02 | 1.719 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.909975e-02 | 1.719 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.971422e-02 | 1.705 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.978769e-02 | 1.704 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.990397e-02 | 1.701 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.996559e-02 | 1.700 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.016417e-02 | 1.695 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.032313e-02 | 1.692 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.059348e-02 | 1.686 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.063870e-02 | 1.685 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.098929e-02 | 1.678 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.147400e-02 | 1.668 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.147400e-02 | 1.668 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.147400e-02 | 1.668 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.398768e-02 | 1.620 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.197727e-02 | 1.658 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.302411e-02 | 1.638 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.302411e-02 | 1.638 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.274840e-02 | 1.643 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.472807e-02 | 1.607 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.359452e-02 | 1.627 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.129187e-02 | 1.672 | 1 | 1 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.398768e-02 | 1.620 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.259013e-02 | 1.646 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.252667e-02 | 1.647 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.259013e-02 | 1.646 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.314087e-02 | 1.636 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.147400e-02 | 1.668 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.472807e-02 | 1.607 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.530218e-02 | 1.597 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.530218e-02 | 1.597 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.553428e-02 | 1.593 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.557687e-02 | 1.592 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.575989e-02 | 1.589 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.575989e-02 | 1.589 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.575989e-02 | 1.589 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.575989e-02 | 1.589 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.628943e-02 | 1.580 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.647306e-02 | 1.577 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.701272e-02 | 1.568 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.721376e-02 | 1.565 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.761777e-02 | 1.559 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.801406e-02 | 1.553 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.828753e-02 | 1.548 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.828753e-02 | 1.548 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.831145e-02 | 1.548 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.913030e-02 | 1.536 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.924352e-02 | 1.534 | 1 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.944936e-02 | 1.531 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.944936e-02 | 1.531 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.960590e-02 | 1.529 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.960590e-02 | 1.529 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.960590e-02 | 1.529 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.960590e-02 | 1.529 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.961555e-02 | 1.528 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.624881e-02 | 1.441 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.601124e-02 | 1.444 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.336641e-02 | 1.477 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.181158e-02 | 1.497 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.624881e-02 | 1.441 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.460750e-02 | 1.461 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.333715e-02 | 1.477 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.779263e-02 | 1.423 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.624881e-02 | 1.441 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.687008e-02 | 1.433 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.325369e-02 | 1.478 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.200734e-02 | 1.495 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.752388e-02 | 1.426 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.620059e-02 | 1.441 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.893340e-02 | 1.410 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.910632e-02 | 1.408 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.970432e-02 | 1.401 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.045449e-02 | 1.393 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.106491e-02 | 1.387 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.128282e-02 | 1.384 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.174025e-02 | 1.379 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.174025e-02 | 1.379 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.207462e-02 | 1.376 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.319500e-02 | 1.365 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.340277e-02 | 1.362 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.383186e-02 | 1.358 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.487779e-02 | 1.348 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.639267e-02 | 1.334 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.828288e-02 | 1.316 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.986878e-02 | 1.302 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.087270e-02 | 1.294 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.206635e-02 | 1.283 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.216346e-02 | 1.283 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.218820e-02 | 1.282 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.218820e-02 | 1.282 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.237038e-02 | 1.281 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.574950e-02 | 1.254 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.574950e-02 | 1.254 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.574950e-02 | 1.254 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.574950e-02 | 1.254 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.574950e-02 | 1.254 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.492932e-02 | 1.260 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.566228e-02 | 1.254 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.566228e-02 | 1.254 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.709728e-02 | 1.173 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.709728e-02 | 1.173 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.709728e-02 | 1.173 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.996967e-02 | 1.222 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.783077e-02 | 1.238 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.484422e-02 | 1.188 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.480425e-02 | 1.261 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.480425e-02 | 1.261 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.277531e-02 | 1.202 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.783077e-02 | 1.238 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.244864e-02 | 1.204 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.445446e-02 | 1.264 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.847001e-02 | 1.233 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.089206e-02 | 1.215 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.492932e-02 | 1.260 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.783077e-02 | 1.238 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.574950e-02 | 1.254 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.566228e-02 | 1.254 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.698040e-02 | 1.174 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.244864e-02 | 1.204 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.103239e-02 | 1.214 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.723061e-02 | 1.172 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.806832e-02 | 1.167 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.835386e-02 | 1.165 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.846314e-02 | 1.165 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.956356e-02 | 1.158 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.956356e-02 | 1.158 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.956356e-02 | 1.158 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.956356e-02 | 1.158 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.043979e-02 | 1.152 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.043979e-02 | 1.152 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.070599e-02 | 1.151 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.150526e-02 | 1.146 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.308427e-02 | 1.136 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.460421e-02 | 1.127 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.475007e-02 | 1.126 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.509385e-02 | 1.124 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.582086e-02 | 1.120 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.857153e-02 | 1.105 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.897222e-02 | 1.103 | 1 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.964888e-02 | 1.099 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.964888e-02 | 1.099 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.034877e-02 | 1.095 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.034877e-02 | 1.095 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.034877e-02 | 1.095 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.042882e-02 | 1.095 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.161060e-02 | 1.088 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 8.198232e-02 | 1.086 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 8.198232e-02 | 1.086 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 8.198232e-02 | 1.086 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.236604e-02 | 1.084 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.504954e-02 | 1.070 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.620981e-02 | 1.064 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.620981e-02 | 1.064 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.620981e-02 | 1.064 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.620981e-02 | 1.064 | 1 | 1 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.692817e-02 | 1.061 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.768067e-02 | 1.057 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.768067e-02 | 1.057 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.873937e-02 | 1.052 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.883808e-02 | 1.051 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.018999e-02 | 1.045 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.018999e-02 | 1.045 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.018999e-02 | 1.045 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.018999e-02 | 1.045 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.111651e-01 | 0.954 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.111651e-01 | 0.954 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.111651e-01 | 0.954 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.111651e-01 | 0.954 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.111651e-01 | 0.954 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.064991e-01 | 0.973 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.064991e-01 | 0.973 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.327490e-02 | 1.030 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.079229e-01 | 0.967 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.079229e-01 | 0.967 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.781350e-02 | 1.010 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.781350e-02 | 1.010 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.747577e-02 | 1.011 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.747577e-02 | 1.011 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.747577e-02 | 1.011 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.149585e-01 | 0.939 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.159963e-01 | 0.936 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.115279e-01 | 0.953 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.208353e-01 | 0.918 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.327490e-02 | 1.030 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.420812e-02 | 1.026 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.060175e-01 | 0.975 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.111651e-01 | 0.954 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.157020e-01 | 0.937 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.060175e-01 | 0.975 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.183733e-01 | 0.927 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.092112e-01 | 0.962 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.072682e-01 | 0.970 | 1 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.111651e-01 | 0.954 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.064991e-01 | 0.973 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.327490e-02 | 1.030 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.067429e-01 | 0.972 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.747577e-02 | 1.011 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.171930e-01 | 0.931 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.171930e-01 | 0.931 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.157020e-01 | 0.937 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.224240e-01 | 0.912 | 1 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.373587e-02 | 1.028 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.171930e-01 | 0.931 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.747577e-02 | 1.011 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.229551e-01 | 0.910 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.235319e-01 | 0.908 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.235319e-01 | 0.908 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.240201e-01 | 0.907 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.242917e-01 | 0.906 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.242917e-01 | 0.906 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.267300e-01 | 0.897 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.275767e-01 | 0.894 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.282778e-01 | 0.892 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.340087e-01 | 0.873 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.343998e-01 | 0.872 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.355973e-01 | 0.868 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.384061e-01 | 0.859 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.400341e-01 | 0.854 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.400341e-01 | 0.854 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.400341e-01 | 0.854 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.400341e-01 | 0.854 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.400341e-01 | 0.854 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.400341e-01 | 0.854 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.400341e-01 | 0.854 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.425468e-01 | 0.846 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.425526e-01 | 0.846 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.425526e-01 | 0.846 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 1.425531e-01 | 0.846 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.425531e-01 | 0.846 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.425531e-01 | 0.846 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 1.425531e-01 | 0.846 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.425531e-01 | 0.846 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.430780e-01 | 0.844 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.476964e-01 | 0.831 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.496660e-01 | 0.825 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.504246e-01 | 0.823 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.509478e-01 | 0.821 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.545527e-01 | 0.811 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.547857e-01 | 0.810 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.573562e-01 | 0.803 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.573562e-01 | 0.803 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.573562e-01 | 0.803 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.574614e-01 | 0.803 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.577220e-01 | 0.802 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.588517e-01 | 0.799 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.590112e-01 | 0.799 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.619141e-01 | 0.791 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.637667e-01 | 0.786 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.722506e-01 | 0.764 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.722506e-01 | 0.764 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.722506e-01 | 0.764 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.722506e-01 | 0.764 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.722506e-01 | 0.764 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.722506e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.722506e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.722506e-01 | 0.764 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.722506e-01 | 0.764 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.469142e-01 | 0.607 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.469142e-01 | 0.607 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.469142e-01 | 0.607 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.469142e-01 | 0.607 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.469142e-01 | 0.607 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.469142e-01 | 0.607 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.755118e-01 | 0.756 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.095030e-01 | 0.679 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.707414e-01 | 0.768 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.440728e-01 | 0.612 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.440728e-01 | 0.612 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 2.440728e-01 | 0.612 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.440728e-01 | 0.612 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.440728e-01 | 0.612 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.440728e-01 | 0.612 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.440728e-01 | 0.612 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.941770e-01 | 0.712 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.941770e-01 | 0.712 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.183417e-01 | 0.661 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.183417e-01 | 0.661 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.183417e-01 | 0.661 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.754211e-01 | 0.756 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.941493e-01 | 0.712 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.430753e-01 | 0.614 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.430753e-01 | 0.614 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.134597e-01 | 0.671 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.332710e-01 | 0.632 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.049636e-01 | 0.688 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.813732e-01 | 0.741 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.387458e-01 | 0.622 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.965493e-01 | 0.707 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.332710e-01 | 0.632 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.332710e-01 | 0.632 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.754211e-01 | 0.756 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.050489e-01 | 0.688 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.087277e-01 | 0.680 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.414919e-01 | 0.617 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.729479e-01 | 0.762 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.941770e-01 | 0.712 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.941493e-01 | 0.712 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.764954e-01 | 0.753 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.755118e-01 | 0.756 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.776166e-01 | 0.751 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.247855e-01 | 0.648 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.032780e-01 | 0.692 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.430753e-01 | 0.614 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.885381e-01 | 0.725 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.994531e-01 | 0.700 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.813732e-01 | 0.741 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.941493e-01 | 0.712 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.134597e-01 | 0.671 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.750105e-01 | 0.757 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.336867e-01 | 0.631 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.717967e-01 | 0.765 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.469142e-01 | 0.607 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.469142e-01 | 0.607 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.469142e-01 | 0.607 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.729479e-01 | 0.762 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.430753e-01 | 0.614 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.252238e-01 | 0.647 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.016633e-01 | 0.695 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.117835e-01 | 0.674 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.941493e-01 | 0.712 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.387458e-01 | 0.622 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.311073e-01 | 0.636 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.332710e-01 | 0.632 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.983239e-01 | 0.703 | 1 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.469142e-01 | 0.607 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.677105e-01 | 0.775 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.734088e-01 | 0.761 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.387458e-01 | 0.622 | 1 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.887107e-01 | 0.724 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.813508e-01 | 0.741 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.440728e-01 | 0.612 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.440728e-01 | 0.612 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.754211e-01 | 0.756 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.965493e-01 | 0.707 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 2.474392e-01 | 0.607 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.497255e-01 | 0.603 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.525413e-01 | 0.598 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.529358e-01 | 0.597 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.529358e-01 | 0.597 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.535024e-01 | 0.596 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.561764e-01 | 0.591 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.561764e-01 | 0.591 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.581520e-01 | 0.588 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.604150e-01 | 0.584 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.625385e-01 | 0.581 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.148470e-01 | 0.502 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.148470e-01 | 0.502 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.148470e-01 | 0.502 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.148470e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.148470e-01 | 0.502 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.148470e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.148470e-01 | 0.502 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.766556e-01 | 0.424 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.766556e-01 | 0.424 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.766556e-01 | 0.424 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.766556e-01 | 0.424 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.766556e-01 | 0.424 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.788405e-01 | 0.555 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.788405e-01 | 0.555 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.788405e-01 | 0.555 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.134896e-01 | 0.504 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.134896e-01 | 0.504 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.134896e-01 | 0.504 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.134896e-01 | 0.504 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.328917e-01 | 0.364 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.328917e-01 | 0.364 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.328917e-01 | 0.364 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 4.328917e-01 | 0.364 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.328917e-01 | 0.364 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.682260e-01 | 0.571 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.682260e-01 | 0.571 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.682260e-01 | 0.571 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.682260e-01 | 0.571 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.477588e-01 | 0.459 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.936515e-01 | 0.532 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.936515e-01 | 0.532 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.740746e-01 | 0.562 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.814347e-01 | 0.419 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.840574e-01 | 0.315 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.840574e-01 | 0.315 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.840574e-01 | 0.315 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.840574e-01 | 0.315 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.840574e-01 | 0.315 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.448087e-01 | 0.462 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.143458e-01 | 0.383 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.143458e-01 | 0.383 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.143458e-01 | 0.383 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.703079e-01 | 0.431 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.703079e-01 | 0.431 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.956171e-01 | 0.403 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.956171e-01 | 0.403 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.463560e-01 | 0.350 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.463560e-01 | 0.350 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.463560e-01 | 0.350 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.463560e-01 | 0.350 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.463560e-01 | 0.350 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.463560e-01 | 0.350 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.306095e-01 | 0.275 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.306095e-01 | 0.275 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.306095e-01 | 0.275 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.306095e-01 | 0.275 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.306095e-01 | 0.275 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.306095e-01 | 0.275 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.306095e-01 | 0.275 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.306095e-01 | 0.275 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.306095e-01 | 0.275 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.306095e-01 | 0.275 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.306095e-01 | 0.275 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.306095e-01 | 0.275 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.306095e-01 | 0.275 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.306095e-01 | 0.275 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.794461e-01 | 0.421 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.794461e-01 | 0.421 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.206467e-01 | 0.376 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.005484e-01 | 0.397 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.005484e-01 | 0.397 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.773601e-01 | 0.321 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.773601e-01 | 0.321 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.560198e-01 | 0.449 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.560198e-01 | 0.449 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.215199e-01 | 0.375 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.215199e-01 | 0.375 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.022933e-01 | 0.395 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.695587e-01 | 0.328 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.072792e-01 | 0.295 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.072792e-01 | 0.295 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.933109e-01 | 0.307 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.098259e-01 | 0.387 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.165221e-01 | 0.287 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.003509e-01 | 0.301 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.065954e-01 | 0.295 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.162021e-01 | 0.287 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.582690e-01 | 0.446 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.332996e-01 | 0.477 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.332996e-01 | 0.477 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.277338e-01 | 0.369 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.453171e-01 | 0.351 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.215199e-01 | 0.375 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.031253e-01 | 0.298 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.682260e-01 | 0.571 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.206467e-01 | 0.376 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.441748e-01 | 0.463 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.567140e-01 | 0.340 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.518156e-01 | 0.345 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.159351e-01 | 0.500 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.933109e-01 | 0.307 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.477588e-01 | 0.459 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.918692e-01 | 0.535 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.740746e-01 | 0.562 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.467620e-01 | 0.460 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.470728e-01 | 0.350 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.857538e-01 | 0.414 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.788405e-01 | 0.555 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.192196e-01 | 0.496 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.143458e-01 | 0.383 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.463560e-01 | 0.350 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.711830e-01 | 0.430 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.628675e-01 | 0.335 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.463560e-01 | 0.350 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.949104e-01 | 0.530 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.628675e-01 | 0.335 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.502244e-01 | 0.347 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.027543e-01 | 0.395 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.682260e-01 | 0.571 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.814347e-01 | 0.419 | 1 | 1 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.840574e-01 | 0.315 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.703079e-01 | 0.431 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.100338e-01 | 0.509 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.815904e-01 | 0.550 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.306095e-01 | 0.275 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.188683e-01 | 0.378 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.031253e-01 | 0.298 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.928052e-01 | 0.307 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.962080e-01 | 0.528 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.962080e-01 | 0.528 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.476890e-01 | 0.459 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.880466e-01 | 0.541 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.164402e-01 | 0.500 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.164402e-01 | 0.500 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.164402e-01 | 0.500 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.164402e-01 | 0.500 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.517947e-01 | 0.345 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.448087e-01 | 0.462 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.072792e-01 | 0.295 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.525001e-01 | 0.453 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.276742e-01 | 0.278 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.846470e-01 | 0.415 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.143458e-01 | 0.383 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.302588e-01 | 0.481 | 1 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.596379e-01 | 0.444 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.160633e-01 | 0.381 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.134896e-01 | 0.504 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.252672e-01 | 0.488 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.567140e-01 | 0.340 | 1 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.766556e-01 | 0.424 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.788405e-01 | 0.555 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.134896e-01 | 0.504 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.328917e-01 | 0.364 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.477588e-01 | 0.459 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.477588e-01 | 0.459 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.192196e-01 | 0.496 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.840574e-01 | 0.315 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.840574e-01 | 0.315 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.143458e-01 | 0.383 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.871034e-01 | 0.542 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.003509e-01 | 0.301 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.712545e-01 | 0.430 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.065954e-01 | 0.295 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.165221e-01 | 0.287 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.956171e-01 | 0.403 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.441748e-01 | 0.463 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.477588e-01 | 0.459 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.370772e-01 | 0.472 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.677755e-01 | 0.330 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.628675e-01 | 0.335 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.164402e-01 | 0.500 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.134896e-01 | 0.504 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.159351e-01 | 0.500 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.463560e-01 | 0.350 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.463560e-01 | 0.350 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.463560e-01 | 0.350 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.463560e-01 | 0.350 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.306095e-01 | 0.275 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.325484e-01 | 0.364 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.032487e-01 | 0.518 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.725628e-01 | 0.429 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.088373e-01 | 0.293 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.347956e-01 | 0.362 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.560198e-01 | 0.449 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.848707e-01 | 0.415 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.570297e-01 | 0.340 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.031253e-01 | 0.298 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.871034e-01 | 0.542 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.871034e-01 | 0.542 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.734501e-01 | 0.428 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.031253e-01 | 0.298 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.463560e-01 | 0.350 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.773601e-01 | 0.321 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.933109e-01 | 0.307 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.134896e-01 | 0.504 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.134896e-01 | 0.504 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.328917e-01 | 0.364 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.328917e-01 | 0.364 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.477588e-01 | 0.459 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.840574e-01 | 0.315 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.306095e-01 | 0.275 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.072792e-01 | 0.295 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.933109e-01 | 0.307 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.031253e-01 | 0.298 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.005484e-01 | 0.397 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.386046e-01 | 0.470 | 1 | 1 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.100338e-01 | 0.509 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.206467e-01 | 0.376 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.453171e-01 | 0.351 | 1 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.796762e-01 | 0.421 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.525897e-01 | 0.344 | 1 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.814347e-01 | 0.419 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.948365e-01 | 0.530 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.453171e-01 | 0.351 | 1 | 1 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.215199e-01 | 0.375 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.100338e-01 | 0.509 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.288345e-01 | 0.483 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.206467e-01 | 0.376 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.918914e-01 | 0.308 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.003509e-01 | 0.301 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.856873e-01 | 0.414 | 1 | 1 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.720644e-01 | 0.326 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.472755e-01 | 0.459 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.766556e-01 | 0.424 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.134896e-01 | 0.504 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.936515e-01 | 0.532 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.840574e-01 | 0.315 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.840574e-01 | 0.315 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.840574e-01 | 0.315 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 4.143458e-01 | 0.383 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.306095e-01 | 0.275 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.388730e-01 | 0.358 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.628675e-01 | 0.335 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.241576e-01 | 0.489 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.353846e-01 | 0.361 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.027390e-01 | 0.519 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.386241e-01 | 0.358 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.788405e-01 | 0.555 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.306095e-01 | 0.275 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.306095e-01 | 0.275 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.306095e-01 | 0.275 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.306095e-01 | 0.275 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.306095e-01 | 0.275 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.933109e-01 | 0.307 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.370772e-01 | 0.472 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.249165e-01 | 0.372 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.132130e-01 | 0.384 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.477588e-01 | 0.459 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.024408e-01 | 0.519 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.840574e-01 | 0.315 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.949104e-01 | 0.530 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.306095e-01 | 0.275 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.463560e-01 | 0.350 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.336973e-01 | 0.363 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.098259e-01 | 0.387 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.787787e-01 | 0.422 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.773601e-01 | 0.321 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.843916e-01 | 0.315 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.755424e-01 | 0.560 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.072792e-01 | 0.295 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.342590e-01 | 0.272 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.360566e-01 | 0.271 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.360566e-01 | 0.271 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.360566e-01 | 0.271 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.360566e-01 | 0.271 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.360566e-01 | 0.271 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.360566e-01 | 0.271 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.360566e-01 | 0.271 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.360566e-01 | 0.271 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.360566e-01 | 0.271 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.360566e-01 | 0.271 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.360566e-01 | 0.271 | 1 | 1 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.388929e-01 | 0.268 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.391484e-01 | 0.268 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.391484e-01 | 0.268 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.419963e-01 | 0.266 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.419963e-01 | 0.266 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.419963e-01 | 0.266 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.419963e-01 | 0.266 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.447065e-01 | 0.264 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.472943e-01 | 0.262 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.500743e-01 | 0.260 | 1 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.521424e-01 | 0.258 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.608363e-01 | 0.251 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.608363e-01 | 0.251 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.611539e-01 | 0.251 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.614420e-01 | 0.251 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.614420e-01 | 0.251 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.625006e-01 | 0.250 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.627737e-01 | 0.250 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.627737e-01 | 0.250 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.627737e-01 | 0.250 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.636549e-01 | 0.249 | 1 | 1 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.636549e-01 | 0.249 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.636549e-01 | 0.249 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.636549e-01 | 0.249 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.636549e-01 | 0.249 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.636549e-01 | 0.249 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.636549e-01 | 0.249 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.637999e-01 | 0.249 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.637999e-01 | 0.249 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.652318e-01 | 0.248 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.652318e-01 | 0.248 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.729639e-01 | 0.242 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.729639e-01 | 0.242 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.729639e-01 | 0.242 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.729639e-01 | 0.242 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.729639e-01 | 0.242 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.729639e-01 | 0.242 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.729639e-01 | 0.242 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.729639e-01 | 0.242 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.729639e-01 | 0.242 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.792464e-01 | 0.237 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.792464e-01 | 0.237 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.798107e-01 | 0.237 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.798107e-01 | 0.237 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.798107e-01 | 0.237 | 1 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.825095e-01 | 0.235 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.842220e-01 | 0.233 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.866318e-01 | 0.232 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.866318e-01 | 0.232 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.900525e-01 | 0.229 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.900525e-01 | 0.229 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.900525e-01 | 0.229 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.900525e-01 | 0.229 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.900525e-01 | 0.229 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.900525e-01 | 0.229 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 5.900525e-01 | 0.229 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.900525e-01 | 0.229 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.900525e-01 | 0.229 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.912424e-01 | 0.228 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.921580e-01 | 0.228 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.921580e-01 | 0.228 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.923099e-01 | 0.227 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.939495e-01 | 0.226 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.972067e-01 | 0.224 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 5.972067e-01 | 0.224 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.031924e-01 | 0.220 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.031924e-01 | 0.220 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.031924e-01 | 0.220 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.031924e-01 | 0.220 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.034373e-01 | 0.219 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.046325e-01 | 0.219 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.046325e-01 | 0.219 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.065829e-01 | 0.217 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.083766e-01 | 0.216 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.114988e-01 | 0.214 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 6.114988e-01 | 0.214 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.114988e-01 | 0.214 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.114988e-01 | 0.214 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.114988e-01 | 0.214 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.114988e-01 | 0.214 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.114988e-01 | 0.214 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.114988e-01 | 0.214 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.114988e-01 | 0.214 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.114988e-01 | 0.214 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.114988e-01 | 0.214 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.114988e-01 | 0.214 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.114988e-01 | 0.214 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.114988e-01 | 0.214 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.127970e-01 | 0.213 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.147001e-01 | 0.211 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.152415e-01 | 0.211 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.152415e-01 | 0.211 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.152415e-01 | 0.211 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.152415e-01 | 0.211 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.152415e-01 | 0.211 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.152415e-01 | 0.211 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.152415e-01 | 0.211 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.154455e-01 | 0.211 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.177888e-01 | 0.209 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.197269e-01 | 0.208 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.207235e-01 | 0.207 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.227910e-01 | 0.206 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.231859e-01 | 0.205 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.231859e-01 | 0.205 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.231859e-01 | 0.205 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.231859e-01 | 0.205 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.309572e-01 | 0.200 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.317129e-01 | 0.199 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.317129e-01 | 0.199 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.337990e-01 | 0.198 | 1 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.345702e-01 | 0.198 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 6.345702e-01 | 0.198 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.392249e-01 | 0.194 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.392249e-01 | 0.194 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.392249e-01 | 0.194 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.392249e-01 | 0.194 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.392249e-01 | 0.194 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.398671e-01 | 0.194 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.424784e-01 | 0.192 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.424784e-01 | 0.192 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.439661e-01 | 0.191 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.465585e-01 | 0.189 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.465585e-01 | 0.189 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.465585e-01 | 0.189 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.465585e-01 | 0.189 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.465585e-01 | 0.189 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.465585e-01 | 0.189 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.465585e-01 | 0.189 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.465585e-01 | 0.189 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.465585e-01 | 0.189 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.465585e-01 | 0.189 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.481144e-01 | 0.188 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.482343e-01 | 0.188 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.482343e-01 | 0.188 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.482343e-01 | 0.188 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.482343e-01 | 0.188 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.482343e-01 | 0.188 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.482343e-01 | 0.188 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.483746e-01 | 0.188 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.610630e-01 | 0.180 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.620151e-01 | 0.179 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.620151e-01 | 0.179 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.620151e-01 | 0.179 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.620151e-01 | 0.179 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.642561e-01 | 0.178 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.642561e-01 | 0.178 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.666036e-01 | 0.176 | 1 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.689609e-01 | 0.175 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.689609e-01 | 0.175 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.742681e-01 | 0.171 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.742681e-01 | 0.171 | 1 | 0 |
| Lipophagy | R-HSA-9613354 | 6.784562e-01 | 0.168 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.784562e-01 | 0.168 | 1 | 1 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.784562e-01 | 0.168 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.784562e-01 | 0.168 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.784562e-01 | 0.168 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.784562e-01 | 0.168 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.784562e-01 | 0.168 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.784562e-01 | 0.168 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.784562e-01 | 0.168 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.789372e-01 | 0.168 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.828151e-01 | 0.166 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.828151e-01 | 0.166 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.830627e-01 | 0.166 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.830627e-01 | 0.166 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.836323e-01 | 0.165 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.836323e-01 | 0.165 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.836323e-01 | 0.165 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.836323e-01 | 0.165 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.868562e-01 | 0.163 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.950525e-01 | 0.158 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.961024e-01 | 0.157 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.961024e-01 | 0.157 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.962734e-01 | 0.157 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.963126e-01 | 0.157 | 1 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.007106e-01 | 0.154 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.009979e-01 | 0.154 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.041024e-01 | 0.152 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.058419e-01 | 0.151 | 1 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.074768e-01 | 0.150 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.074768e-01 | 0.150 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.074768e-01 | 0.150 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.074768e-01 | 0.150 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.074768e-01 | 0.150 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.074768e-01 | 0.150 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.074768e-01 | 0.150 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.074768e-01 | 0.150 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.074768e-01 | 0.150 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.074768e-01 | 0.150 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.074768e-01 | 0.150 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.074768e-01 | 0.150 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.074768e-01 | 0.150 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.092789e-01 | 0.149 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.106450e-01 | 0.148 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.106450e-01 | 0.148 | 1 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.125629e-01 | 0.147 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.125629e-01 | 0.147 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.125629e-01 | 0.147 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.137843e-01 | 0.146 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.151804e-01 | 0.146 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.151804e-01 | 0.146 | 1 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.205833e-01 | 0.142 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.219937e-01 | 0.141 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.219937e-01 | 0.141 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.219937e-01 | 0.141 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.232682e-01 | 0.141 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.232682e-01 | 0.141 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.234564e-01 | 0.141 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.234564e-01 | 0.141 | 1 | 1 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.234564e-01 | 0.141 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.234564e-01 | 0.141 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.234564e-01 | 0.141 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.245573e-01 | 0.140 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.262165e-01 | 0.139 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.281689e-01 | 0.138 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.283265e-01 | 0.138 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.283265e-01 | 0.138 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.338798e-01 | 0.134 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.338798e-01 | 0.134 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.338798e-01 | 0.134 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.338798e-01 | 0.134 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.338798e-01 | 0.134 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.338798e-01 | 0.134 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.338798e-01 | 0.134 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.338798e-01 | 0.134 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.338798e-01 | 0.134 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.342544e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.366668e-01 | 0.133 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.366668e-01 | 0.133 | 1 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.367511e-01 | 0.133 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.367511e-01 | 0.133 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.393059e-01 | 0.131 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.398314e-01 | 0.131 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.417290e-01 | 0.130 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.417290e-01 | 0.130 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.417290e-01 | 0.130 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.417290e-01 | 0.130 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.417290e-01 | 0.130 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.434031e-01 | 0.129 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.434031e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.434031e-01 | 0.129 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.434031e-01 | 0.129 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.434031e-01 | 0.129 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.434031e-01 | 0.129 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.464956e-01 | 0.127 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.497316e-01 | 0.125 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.545118e-01 | 0.122 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.571576e-01 | 0.121 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.575823e-01 | 0.121 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.578051e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.578051e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.578051e-01 | 0.120 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.578051e-01 | 0.120 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.578051e-01 | 0.120 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.579011e-01 | 0.120 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.579011e-01 | 0.120 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.579011e-01 | 0.120 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.579011e-01 | 0.120 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 7.579011e-01 | 0.120 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.579011e-01 | 0.120 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.579011e-01 | 0.120 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.579011e-01 | 0.120 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.579011e-01 | 0.120 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.579011e-01 | 0.120 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.579011e-01 | 0.120 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.579011e-01 | 0.120 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.589576e-01 | 0.120 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.589576e-01 | 0.120 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.589576e-01 | 0.120 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.589576e-01 | 0.120 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.657560e-01 | 0.116 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.685146e-01 | 0.114 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.697189e-01 | 0.114 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.737581e-01 | 0.111 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.742076e-01 | 0.111 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.742076e-01 | 0.111 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.742091e-01 | 0.111 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.751818e-01 | 0.111 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.758620e-01 | 0.110 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.793384e-01 | 0.108 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.797554e-01 | 0.108 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.797554e-01 | 0.108 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.797554e-01 | 0.108 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.797554e-01 | 0.108 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.797554e-01 | 0.108 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.797554e-01 | 0.108 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.797554e-01 | 0.108 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.797554e-01 | 0.108 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.797554e-01 | 0.108 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.797554e-01 | 0.108 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.797554e-01 | 0.108 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.797554e-01 | 0.108 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.797554e-01 | 0.108 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.797554e-01 | 0.108 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.825449e-01 | 0.106 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.832988e-01 | 0.106 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.846431e-01 | 0.105 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.857208e-01 | 0.105 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.904425e-01 | 0.102 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.904425e-01 | 0.102 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.904425e-01 | 0.102 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.904425e-01 | 0.102 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.904425e-01 | 0.102 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.904425e-01 | 0.102 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.967595e-01 | 0.099 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.967595e-01 | 0.099 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.971119e-01 | 0.098 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.979788e-01 | 0.098 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.979788e-01 | 0.098 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.996381e-01 | 0.097 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.996381e-01 | 0.097 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.996381e-01 | 0.097 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.996381e-01 | 0.097 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.996381e-01 | 0.097 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.996381e-01 | 0.097 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.996381e-01 | 0.097 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.047814e-01 | 0.094 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.047814e-01 | 0.094 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.047814e-01 | 0.094 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.047814e-01 | 0.094 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.051313e-01 | 0.094 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.073348e-01 | 0.093 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.089708e-01 | 0.092 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.089708e-01 | 0.092 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.091057e-01 | 0.092 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 8.177270e-01 | 0.087 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.177270e-01 | 0.087 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.177270e-01 | 0.087 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.177270e-01 | 0.087 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.177270e-01 | 0.087 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.177270e-01 | 0.087 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.182405e-01 | 0.087 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.182405e-01 | 0.087 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.182877e-01 | 0.087 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.182877e-01 | 0.087 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.202389e-01 | 0.086 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.267916e-01 | 0.083 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.267916e-01 | 0.083 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.271381e-01 | 0.082 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.291103e-01 | 0.081 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.308034e-01 | 0.081 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.308618e-01 | 0.080 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.308618e-01 | 0.080 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.308618e-01 | 0.080 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.309354e-01 | 0.080 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.319082e-01 | 0.080 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.341837e-01 | 0.079 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.341837e-01 | 0.079 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.341837e-01 | 0.079 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.341837e-01 | 0.079 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.341837e-01 | 0.079 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.372161e-01 | 0.077 | 1 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.410805e-01 | 0.075 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.410805e-01 | 0.075 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.410805e-01 | 0.075 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.426867e-01 | 0.074 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.470089e-01 | 0.072 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.491555e-01 | 0.071 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.491555e-01 | 0.071 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.491555e-01 | 0.071 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.491555e-01 | 0.071 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.491555e-01 | 0.071 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.491555e-01 | 0.071 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.491555e-01 | 0.071 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.491555e-01 | 0.071 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.491555e-01 | 0.071 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.491555e-01 | 0.071 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.491555e-01 | 0.071 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.537562e-01 | 0.069 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.597969e-01 | 0.066 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.627763e-01 | 0.064 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.627763e-01 | 0.064 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.627763e-01 | 0.064 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.627763e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.627763e-01 | 0.064 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.632619e-01 | 0.064 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.641103e-01 | 0.063 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.641103e-01 | 0.063 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.647332e-01 | 0.063 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.693364e-01 | 0.061 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.708027e-01 | 0.060 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.737877e-01 | 0.059 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.751679e-01 | 0.058 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.751679e-01 | 0.058 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.751679e-01 | 0.058 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.751679e-01 | 0.058 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.751679e-01 | 0.058 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.751679e-01 | 0.058 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.765506e-01 | 0.057 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.765506e-01 | 0.057 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.765506e-01 | 0.057 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.765506e-01 | 0.057 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.776381e-01 | 0.057 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.828263e-01 | 0.054 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.832449e-01 | 0.054 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.842420e-01 | 0.053 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.842420e-01 | 0.053 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.842420e-01 | 0.053 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.864412e-01 | 0.052 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.864412e-01 | 0.052 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.864412e-01 | 0.052 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.864412e-01 | 0.052 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.864412e-01 | 0.052 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.864412e-01 | 0.052 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.901446e-01 | 0.051 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.912625e-01 | 0.050 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.912625e-01 | 0.050 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.912625e-01 | 0.050 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.912625e-01 | 0.050 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.912625e-01 | 0.050 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.915028e-01 | 0.050 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.917484e-01 | 0.050 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.948510e-01 | 0.048 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.966970e-01 | 0.047 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.966970e-01 | 0.047 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.966970e-01 | 0.047 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.966970e-01 | 0.047 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.966970e-01 | 0.047 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.966970e-01 | 0.047 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.966970e-01 | 0.047 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.966970e-01 | 0.047 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.966970e-01 | 0.047 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.966970e-01 | 0.047 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.966970e-01 | 0.047 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.991314e-01 | 0.046 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.991314e-01 | 0.046 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.991314e-01 | 0.046 | 1 | 1 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.034762e-01 | 0.044 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.034762e-01 | 0.044 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.050310e-01 | 0.043 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.060272e-01 | 0.043 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.060272e-01 | 0.043 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.060272e-01 | 0.043 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.060272e-01 | 0.043 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.060272e-01 | 0.043 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.060272e-01 | 0.043 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.060272e-01 | 0.043 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.060272e-01 | 0.043 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.060272e-01 | 0.043 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.060272e-01 | 0.043 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.064665e-01 | 0.043 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.108943e-01 | 0.041 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.133001e-01 | 0.039 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.133001e-01 | 0.039 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.133001e-01 | 0.039 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.133001e-01 | 0.039 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.133001e-01 | 0.039 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.143497e-01 | 0.039 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.145152e-01 | 0.039 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.145152e-01 | 0.039 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.145152e-01 | 0.039 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.145152e-01 | 0.039 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.145152e-01 | 0.039 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.145152e-01 | 0.039 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.145152e-01 | 0.039 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.166231e-01 | 0.038 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.166231e-01 | 0.038 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.166231e-01 | 0.038 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.187033e-01 | 0.037 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.196629e-01 | 0.036 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.196629e-01 | 0.036 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.220141e-01 | 0.035 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.220141e-01 | 0.035 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.220141e-01 | 0.035 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.222369e-01 | 0.035 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.222369e-01 | 0.035 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.222369e-01 | 0.035 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.222369e-01 | 0.035 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.222369e-01 | 0.035 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.222369e-01 | 0.035 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.222369e-01 | 0.035 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.222369e-01 | 0.035 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.222369e-01 | 0.035 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.222369e-01 | 0.035 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.232168e-01 | 0.035 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.248833e-01 | 0.034 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.255842e-01 | 0.034 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.255842e-01 | 0.034 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.255842e-01 | 0.034 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.259531e-01 | 0.033 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.268337e-01 | 0.033 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.270844e-01 | 0.033 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.277646e-01 | 0.033 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.277646e-01 | 0.033 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.289359e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.292616e-01 | 0.032 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.292616e-01 | 0.032 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.310917e-01 | 0.031 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.310917e-01 | 0.031 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.310917e-01 | 0.031 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.310917e-01 | 0.031 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.317109e-01 | 0.031 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.324436e-01 | 0.030 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.342396e-01 | 0.030 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.356521e-01 | 0.029 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.356521e-01 | 0.029 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.356521e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.356521e-01 | 0.029 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.356521e-01 | 0.029 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.361381e-01 | 0.029 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.362119e-01 | 0.029 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.362119e-01 | 0.029 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.362119e-01 | 0.029 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.362119e-01 | 0.029 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.363278e-01 | 0.029 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.399855e-01 | 0.027 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.405321e-01 | 0.027 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.409699e-01 | 0.026 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.409699e-01 | 0.026 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.409699e-01 | 0.026 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.409699e-01 | 0.026 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.412522e-01 | 0.026 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.414656e-01 | 0.026 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.414656e-01 | 0.026 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.414656e-01 | 0.026 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.414656e-01 | 0.026 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.414656e-01 | 0.026 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.415272e-01 | 0.026 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.427203e-01 | 0.026 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.427895e-01 | 0.026 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.444779e-01 | 0.025 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.452456e-01 | 0.024 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.453891e-01 | 0.024 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.453891e-01 | 0.024 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.453891e-01 | 0.024 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.453891e-01 | 0.024 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.467542e-01 | 0.024 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.467542e-01 | 0.024 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.467542e-01 | 0.024 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.467542e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.467542e-01 | 0.024 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.467542e-01 | 0.024 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.467542e-01 | 0.024 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.467542e-01 | 0.024 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.479585e-01 | 0.023 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.494921e-01 | 0.023 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.494921e-01 | 0.023 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.494921e-01 | 0.023 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.494921e-01 | 0.023 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.494921e-01 | 0.023 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.515653e-01 | 0.022 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.515653e-01 | 0.022 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.515653e-01 | 0.022 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.515653e-01 | 0.022 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.515653e-01 | 0.022 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.515653e-01 | 0.022 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.532998e-01 | 0.021 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.532998e-01 | 0.021 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.536370e-01 | 0.021 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.537420e-01 | 0.021 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.559419e-01 | 0.020 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.559419e-01 | 0.020 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.559419e-01 | 0.020 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.559419e-01 | 0.020 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.559419e-01 | 0.020 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.568321e-01 | 0.019 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.579492e-01 | 0.019 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.589338e-01 | 0.018 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.599233e-01 | 0.018 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.599233e-01 | 0.018 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.599233e-01 | 0.018 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.599233e-01 | 0.018 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.600028e-01 | 0.018 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.600028e-01 | 0.018 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.600028e-01 | 0.018 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.601076e-01 | 0.018 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.601076e-01 | 0.018 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.601076e-01 | 0.018 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.601076e-01 | 0.018 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.608022e-01 | 0.017 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.608022e-01 | 0.017 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.624028e-01 | 0.017 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.631439e-01 | 0.016 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.631439e-01 | 0.016 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.631439e-01 | 0.016 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.635451e-01 | 0.016 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.635451e-01 | 0.016 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.635451e-01 | 0.016 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.635451e-01 | 0.016 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.635451e-01 | 0.016 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.659575e-01 | 0.015 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.659575e-01 | 0.015 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.667436e-01 | 0.015 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.668398e-01 | 0.015 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.668398e-01 | 0.015 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.668398e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.668398e-01 | 0.015 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.677503e-01 | 0.014 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.685638e-01 | 0.014 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.687397e-01 | 0.014 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.696630e-01 | 0.013 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.698369e-01 | 0.013 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.698369e-01 | 0.013 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.699059e-01 | 0.013 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.704917e-01 | 0.013 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.709772e-01 | 0.013 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.714701e-01 | 0.013 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.714701e-01 | 0.013 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.725330e-01 | 0.012 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.725633e-01 | 0.012 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.731770e-01 | 0.012 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.732115e-01 | 0.012 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.749117e-01 | 0.011 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.750434e-01 | 0.011 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.750434e-01 | 0.011 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.750434e-01 | 0.011 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.766398e-01 | 0.010 | 1 | 1 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.771919e-01 | 0.010 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.771919e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.772994e-01 | 0.010 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.772994e-01 | 0.010 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.789612e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.793038e-01 | 0.009 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.793517e-01 | 0.009 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.793517e-01 | 0.009 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.793517e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.793517e-01 | 0.009 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.793517e-01 | 0.009 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.793517e-01 | 0.009 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.793517e-01 | 0.009 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.802126e-01 | 0.009 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.803746e-01 | 0.009 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.805970e-01 | 0.009 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.806922e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.812185e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.812185e-01 | 0.008 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.812185e-01 | 0.008 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.827111e-01 | 0.008 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.829166e-01 | 0.007 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.829166e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.829166e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.829166e-01 | 0.007 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.844613e-01 | 0.007 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.844613e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.844613e-01 | 0.007 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.846615e-01 | 0.007 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.847138e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.858664e-01 | 0.006 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.858664e-01 | 0.006 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.858664e-01 | 0.006 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.859904e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.867785e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.870917e-01 | 0.006 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.871445e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.876588e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.877193e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.877193e-01 | 0.005 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.881085e-01 | 0.005 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.881085e-01 | 0.005 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.882111e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.882478e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.883071e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.883071e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.890470e-01 | 0.005 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.893600e-01 | 0.005 | 1 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.893646e-01 | 0.005 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.893646e-01 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.894202e-01 | 0.005 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.896856e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.903266e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.903266e-01 | 0.004 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.907315e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.911943e-01 | 0.004 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.919974e-01 | 0.003 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.920757e-01 | 0.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.926557e-01 | 0.003 | 1 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.927214e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.927214e-01 | 0.003 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.927214e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.927214e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.927214e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.929438e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.937665e-01 | 0.003 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.943377e-01 | 0.002 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.946904e-01 | 0.002 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.947661e-01 | 0.002 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.950191e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.952266e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.952266e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.954107e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.954107e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.956104e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.959370e-01 | 0.002 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.959370e-01 | 0.002 | 1 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.959489e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.962527e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.963588e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.965890e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.971186e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.971283e-01 | 0.001 | 1 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.971809e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.972298e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.973522e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.973522e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.973522e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.974361e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.976064e-01 | 0.001 | 1 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.976682e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.978793e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.978897e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.980490e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.980815e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.981123e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.982680e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.982764e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.984850e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.985492e-01 | 0.001 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.986852e-01 | 0.001 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.988001e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.988001e-01 | 0.001 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.989088e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.989449e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.990190e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.990543e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.991793e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.992474e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.992536e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.992594e-01 | 0.000 | 1 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.992639e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.993827e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.993827e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.994387e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.994895e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.994965e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.995358e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.995618e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.995717e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995717e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.995779e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.996161e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996265e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.996315e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.996945e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.997369e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997375e-01 | 0.000 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.997613e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.997829e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.998317e-01 | 0.000 | 1 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998666e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999161e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999203e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999427e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999462e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999608e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999718e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999799e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999818e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999830e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999830e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999899e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999904e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999921e-01 | 0.000 | 1 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.999924e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999967e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999977e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999978e-01 | 0.000 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999978e-01 | 0.000 | 1 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999985e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999991e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999991e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999997e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signal amplification | R-HSA-392518 | 1.000000e+00 | 0.000 | 1 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.000000e+00 | 0.000 | 1 | 1 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
